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Production of recombinant proteins is typically done in bacteria, i.e. E. coli, since 
they can be grown quickly, inexpensively and can be used to express a variety of 
proteins.  However, obstacles, such as the presence of cytoplasmic proteases and low 
periplasmic protein yields, exist that prevent E. coli from being more widely used for 
protein production.  By using the methods of protein engineering coupled with high-
throughput screening by Fluorescence Activated Cell Sorting (FACS), recombinant 
protein yields in E. coli may be increased which would lead to the greater utilization of E. 
coli as a recombinant protein production host. 
The recently discovered Twin Arginine Translocation (Tat) system allows the 
export of fully-folded proteins across the inner cell membrane of E. coli.  The Tat system 
now allows protein engineers to take advantage of the available protein folding 
machinery in the cytoplasm, expanding the range of recombinant proteins that can be 
produced in bacteria.  However, since the efficiency and yield of export via Tat is low, 
 vi
we sought to examine whether mutations within the mature part of the protein can result 
in increased yield of periplasmic proteins.  Using directed evolution and FACS, the 
export of the anti-digoxin 26-10 scFv was increased in an oxidizing strain of E. coli.  One 
isolated clone showed increased export of 26-10 to the periplasm.  In vitro analysis of the 
thermodynamic stability and folding kinetics indicated that the mutant scFv exhibits 
faster folding kinetics, and this is likely to be responsible for the improved export to the 
periplasmic space.   
In addition, in order further increase the export of the 26-10 scFv through the Tat 
pathway, we examined the effect of the co-expression of certain chaperone and Tat 
translocon proteins that were previously shown to partially relieve the saturation of the 
Tat pathway.  Co-expression of the Tat translocon proteins, TatA, TatB and TatC, 
resulted in an additional 2.4-fold increase in cell fluorescence yielding an overall cell 
fluorescence increase of 5-fold as compared to the parental 26-10 scFv.  The effect of 
media, pH and temperature and the use of different oxidizing strains of E. coli on cell 
fluorescence and growth were also investigated but did not yield any improvement on 
cell fluorescence.   
Finally, flow cytometry was utilized in an attempt to develop a genetic system for 
the better understanding of the Clp system and for studying how amino acid substitutions 
might affect the mechanical stability of protein substrates.  The Clp system recognizes 
proteins tagged for degradation, unfolds them by applying a mechanical force to the 
protein and degrades them into smaller peptides.  A FACS screen was employed to 
screen a genomic library for genes that can act as negative regulators of ClpXP 
degradation.  Unfortunately, no such genes could be isolated.  In addition, since the 
system applies a mechanical force to unfold proteins, the Clp system could be used as an 
assay to engineer more stable proteins against mechanical denaturation.  Using GFP 
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tagged with the SsrA peptide as a fluorescent reporter in a FACS assay,  the screening of 
several mutant libraries indicated that no mutations could stabilize GFP against 
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Introduction, Background and State of the Art 
 
1.1 INTRODUCTION 
Protein engineering is the application of science and engineering to improve 
existing proteins and enzymes.  Two different, but complementary, strategies are used in 
protein engineering.   Rational protein design takes advantage of the knowledge of a 
protein’s structure and function to make directed amino acid changes in order to improve 
certain properties of the protein.  However, since the detailed structure of a protein may 
not be known, it is difficult to predict the location and changes necessary to obtain the 
desired results.  The second approach to protein engineering, which does not require 
detailed structural or functional information, includes several strategies collectively 
termed directed evolution.  In the most common application of directed evolution, 
random mutagenesis is applied to the whole protein, and a selection method is used that 
can result in the isolation of the individual mutant proteins with the desired properties.  
Multiple rounds of mutation and selection can be utilized to further enhance the 
properties of the isolated clones.  However, directed evolution requires high-throughput 
screening (HTS) methods in order to ensure that a large number of combinations of 
random mutations are investigated.  Thus, in any directed evolution experiment, the 




1.1.1 Protein Engineering and Antibodies 
The capabilities of protein engineering have been increasing as more knowledge 
of protein structure and function becomes available along with advancements in high-
throughput screening.  The first successes of protein engineering improved a protein’s 
physical properties to withstand varying environmental conditions such as pH and 
temperature [1].  More recently, researchers have been able to engineer proteins with 
desirable therapeutic properties for the specific delivery of drugs to increase their potency 
and reduce possible side effects [2-4].  More importantly, a special class of proteins 
known as antibodies can be engineered to target biologically important molecules like 
hormones or their receptors [5, 6].  There are currently 18 antibodies approved for 
therapeutic use in the United States [7] with another 150 in clinical development [8].   
An antibody, or immunoglobulin, is produced by the immune system to recognize 
specific antigens such as bacteria, viruses, and infected cells.  Upon binding to a unique 
target, the antibody tags the microbe or infected cell for clearance by other parts of the 
immune system.  In addition, targets can also be neutralized when the binding antibody 
blocks an essential part of the microorganism necessary for its survival or invasion of the 
host cell.  The most prevalent immunoglobulin in human serum is immunoglobulin G 
(IgG).  It consists of four polypeptide chains, 2 identical light chains and 2 identical 
heavy chains in a characteristic ‘Y’ shape (see Figure 1.1, [7]).  A disulfide bond links 
each half of the ‘Y’.  The Fc region of the IgG (CH2 and CH3) is also known as the 
constant fragment and is responsible for the effector functions (i.e. macrophage 
recognition and complement activation) of the IgG during an immune response.  The 
antigen binding fragment or Fab makes up each of the arms of the ‘Y’ shape and contains 
one set of variable chains (VH and VL) and their associated constant chains (CH1 and 
Cλ(κ)).  The variable fragment (Fv) region on the end of each Fab consists of the VH and 
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VL chains, and each chain has three hypervariable loops known as complementary 
determining regions (CDRs).  The polypeptide regions surrounding the CDRs are known 
as the framework regions, and along with the CDRs, play a role in the antigen binding 
properties of the antibody.  By targeting the CDRs and framework regions at the nucleic 
acid level, the antigen binding properties can be altered to increase an antibody’s 
specificity or affinity. 
 
 
Figure 1.1. Diagram of an IgG and scFv antibody.  Single-chain antibody fragments are 
comprised of the variable domains from the heavy (VH) and light chain (VL) of the IgG joined by 
a peptide linker of about 15 amino acids.  Constant domains (C) of both the heavy and light 
chains are linked by disulfide bonds shown as green lines.  Figure adapted from [7]. 
 
Since the binding domain of the antibody is comprised of the VH and VL chains, it 
is only necessary to manipulate these two chains to alter the specificity or affinity of the 
antibody.  Therefore, it was these two regions that were first amplified and expressed in 
microbial hosts [9].  In order to produce a single-chain antibody fragment (scFv), a 
flexible peptide linker was added between the two variable domains [10].  The scFv 
represents one entire binding site of the antibody molecule and can be easily expressed in 
bacteria.  The small fragment size (~30 kDa compared to ~150 kDa for IgG) is easier to 
express and produce in microbial cells which lowers production time and costs.  In 
 4
addition, since the affinity of scFvs is similar to each of the binding sites on an IgG 
molecule [11], the scFv can be used in conjunction with recombinant DNA techniques in 
bacteria as a means to engineer improved antibodies.  Several antibody fragments are in 
clinical development for multiple diseases including cancer [12].  However, product 
yields of antibody fragments in Escherichia coli (E. coli) have been inadequate, and 
therefore protein engineering can play a vital role in increasing the expression and overall 



















1.2 HIGH-THROUGHPUT SCREENING AND PROTEIN ENGINEERING 
1.2.1 Directed Evolution 
A combinatorial library is a collection of cloned DNA genes or proteins that have 
been mutated such that different combinations of amino acids are represented.  These 
libraries can be constructed by various methods including error-prone polymerase chain 
reaction (PCR) in which the whole or part of a gene is mutated [13, 14].  Directed 
evolution relies on the creation of these libraries which can then be screened for “gain of 
function” mutants towards a specific application [15].  Directed evolution is typically an 
iterative approach: the gene encoding the protein of interest is mutated to create the 
library of gene variants, the library is screened to isolate the clones that posses the desired 
properties and the isolated clones can then be subjected to additional rounds of mutation 
and selection. 
In order for directed evolution to be successful, mutations at the DNA level have 
to be linked to changes in the protein’s function.  In other words, the genotype (DNA 
level) must be linked to the phenotype (i.e. a function mediated by the protein), and this 
linkage must be maintained through the selection or screening process.  Since any 
combinatorial approach relies on methods for the rapid measurement of the phenotypes of 
the mutant library to identify the clones with improved properties [16], the linkage 
method is typically developed with the selection system in mind.   
Screening individual clones on microtiter well plates or agar plates limits the 
amount of clones that can be examined effectively to typically 104 [17].  HTS methods 
which typical employ fluorescence for detection of the desired function can be employed 
to interrogate a larger number of cells producing different mutant proteins.  For example, 
using HTS and a fluorescent phenotype, directed evolution has allowed for the 
engineering of enzymes with increased substrate affinity [18, 19]. 
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1.2.2 Microbial Cell Display 
One method to establish a link between genotype and phenotype is microbial cell 
display.  This approach involves the expression of protein libraries via plasmid 
expression vectors in a suitable host organism, typically bacteria or yeast.  However, the 
location of protein expression in Gram-negative bacteria, such as E. coli, can determine 
the type of display system used. 
The periplasmic space of E. coli, located between the lipopolysaccharide outer 
membrane and the inner membrane, has an oxidizing environment which allows for the 
formation of disulfide bonds  (see Figure 1.2, [20]).  Proteins that contain disulfide bonds 
are therefore typically expressed in the periplasm to allow the protein to fold correctly.  
The cytoplasm, on the other hand, has a reducing environment and contains the majority 
of the cell’s folding machinery [21] such as molecular chaperones that prevent protein 
aggregation [22].  Hence, cytoplasmic expression may allow these chaperones to help 




Figure 1.2. The cell envelop of Gram negative bacteria.  The inner membrane separates the 
cytoplasm from the periplasmic space, while the outer membrane separates the periplasmic space 
from the extracellular environment.  The inner membrane is a phospholipid bilayer while the 
outer membrane is comprised of a phospholipid leaflet and a lipopolysaccharide leaflet.  Also 
shown is the peptidoglycan wall connected to the outer membrane by lipoproteins and embedded 
proteins in both membranes.  Figure adapted from [20]. 
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In E. coli display systems, the proteins are usually expressed in the periplasm to 
allow for correct folding.  Secreted proteins can be anchored to the periplasmic side of 
the inner membrane.  Typically, when screening antibody libraries displayed in bacteria 
or yeast, the cells are incubated with fluorescently labeled antigen to allow selection 
based on the fluorescence level.  Therefore, cells isolated based on high fluorescence may 
indicate an increase in the affinity of the antibody or an increase in the number of 
antibodies displayed by each cell.  This results in the ability to select for mutant 
antibodies with better expression levels, export, or folding properties or increased 
amounts of soluble protein. 
The high-throughput analysis and selection of antibodies exhibiting higher 
fluorescence is typically carried out using a method known as flow cytometry (described 
in detail in a later section) [23].   More specifically, flow cytometry has been used to sort 
and isolate high-affinity antibodies against a target antigen [23-25].   
However, most fluorescent ligands cannot enter microbial cells so the protein of 
interest must be accessible to the extracellular fluid.  In order to accomplish this, the 
Periplasmic Expression with Cytometric Screening (PECS) [25] system relies on the 
export of the protein into the periplasm of E. coli and permeabilization of the outer 
membrane to allow access by fluorescent ligands (see Figure 1.3).  This allows 
fluorescent molecules to enter the periplasm without the leakage of proteins from the 
periplasm or a loss in cell viability [25].  Since the fluorescent marker enters from the 
extracellular space, no fusion partners are needed to tag the protein.  In addition, only 
soluble proteins will be selected since insoluble protein will not bind the fluorescent 
ligand and be selected, which is useful for purification and characterization.  Thus, the 
PECS system allows the screening of large protein libraries while providing the necessary 




Figure 1.3. PECS diagram.  Cells expressing the protein of interest shown as single chain 
antibody fragments (scFv) are incubated in hypertonic buffer (i.e. buffer of high osmolarity such 
as 5xPBS (phosphate buffered saline)) to permeabilize the outer membrane to the fluorescently 
labeled antigen (green symbols).  The cells are then washed to remove unbound antigen, and cells 
are selected on their level of fluorescence.  
 
1.2.3 Flow Cytometry (FC)   
Flow cytometry is able to analyze multiple properties of single cells in a large 
population quickly and it has become widely used as a HTS method [26].  Flow 
cytometry can measure phenotypic and molecular properties of individual cells using 
fluorescent probes or markers which bind to specific molecules in or on the cell [27], and 
it has been used to simultaneously measure 13 different cellular parameters [28].  Cells 
are forced to flow single file in front of a laser beam.  As the cells flow by, the laser 
excites the fluorescent molecules, and the emitted light is collected by detectors which 
then translate the light into a proportional electronic signal.  In addition, the diffracted 
light or forward scatter is related to the cell surface area while reflected and refracted 




Figure 1.4. Simplified diagram of a flow cytometer.  As shown, a laser is focused at the 
interrogation point at which cells pass through individually.  Properties of the cell can be 
determined by the light collected by the side scatter and forward scatter detectors and by the 
fluorescence detectors.  Different filters can be used depending upon the excitation and emission 
spectra of the fluorescent probes used.  Figure adapted from [27]. 
 
Fluorescence Activated Cell Sorting (FACS) is routinely used in research settings 
to conduct immunophenotyping, cell counting, DNA analysis and isolation of antibody 
fragments that bind target antigens by sorting [23, 29].  During FACS, a population of 
cells is defined by its forward and side-scatter characteristics, and then individual cells 
can be collected from the population based on their fluorescence.  When a cell’s 
properties match the sort criteria, the FACS system moves a catcher tube into the fluid 
stream to capture that single cell (see Figure 1.5, [30]).  The catcher tube can move in and 
out of the cell stream approximately 300 times per second, and the FACS system can sort 
over 107 events per hour [31].  It has been shown that even at these high sort rates, rare 
clones with frequencies as low as 106 to 107 can be isolated from heterogeneous 
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populations [32, 33].  Due to the quantitative information collected about each cell in the 
library, FACS can provide a means to optimize library construction and sorting 
conditions to better obtain clones of interest [34, 35].  Thus, this high-throughput 
screening method coupled with the quantitative analysis of flow cytometry has made 
FACS a useful tool for isolating mutants of interest from protein libraries. 
 
 
Figure 1.5. Schematic of cell sorting system.  As the individual cells pass the laser, its 
fluorescence is detected and compared with the set sort conditions.  If the sort conditions are 
satisfied, a catcher tube will move into the stream to collect the cell.  Otherwise, the cell will 






1.3 PROTEIN ENGINEERING AND PRODUCTION 
The current biopharmaceutical protein market generates over $30 billion per year 
in revenue and is expected to double by the end of the decade [36, 37].  The majority of 
recombinant proteins are currently produced in bacteria due the lower cost, higher yields, 
and ease of growth in the laboratory [21, 38, 39].  Specifically, E. coli bacteria are used 
for about 40% of the total recombinant protein production [36]. 
However, obstacles exist that prevent E. coli from being more widely used for 
protein production.  Although cytoplasmic protein expression allows the protein to take 
advantage of the molecular chaperones, cofactors, and foldases present in the cytoplasm 
to ensure proper folding, the cytoplasm also contains many protease systems.  One such 
system, the E. coli Clp system (discussed below), can reduce protein yields through 
degradation.  Being able to control proteases such as those in the Clp system would 
reduce cytoplasmic degradation of recombinant proteins.   
The export of proteins into the periplasm may improve yields and also reduce 
further downstream processing that would normally be required to remove cytoplasmic 
components.  Since the periplasm lacks many of the chaperones of the cytoplasm, 
exporting fully folded proteins to the periplasm is desirable.  In bacteria, the Twin 
Arginine Translocation (Tat) pathway (discussed in detail in a later section) is the only 
known system that functions to transport folded proteins across the cytoplasmic 
membrane.  However, this process is relatively inefficient, resulting in low protein yields 
particularly when compared to the export pathways that transport polypeptides in an 
unfolded conformation.  Nevertheless, protein engineering can be utilized to increase the 
efficiency of export by increasing the export competence of the protein.  In addition, 
engineering the export machinery or new strains of E. coli may also increase export flux.  
Therefore, protein engineering coupled with HTS can be used to increase recombinant 
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1.4.1 Protein Export in E. coli 
For protein production purposes, it is often necessary to transport the proteins out 
of the cytoplasm after they are synthesized [40] since cytoplasmic expression leads to 
additional downstream processing steps.  For instance, cytoplasmic proteins must be 
harvested after disruption of both cell walls and separated from all other unwanted 
cytoplasmic components whereas disruption of the outer membrane and collection of 
periplasmic proteins is less complicated [41].  In addition, protein aggregation in the 
cytoplasm can occur when overexpressing a heterologous protein [42, 43] which requires 
additional steps to refold the protein to obtain its biologically active form [36].  Finally, 
the total product yield may be affected by cytoplasmic protease degradation. 
For the above reasons, the expression of proteins in secreted form is highly 
desirable for biotechnology purposes.  Bacteria contain multiple protein export pathways.  
The two most important pathways, designated as Sec and Tat are similar in that they 1) 
use a signal peptide or N-terminal tag to target the protein to the pathway translocon, 2) 
use an energy source to translocate the protein through the pore, and 3) maintain the 
integrity and function of the inner membrane while allowing large proteins to be 
transported.  Both of these pathways are briefly discussed in the following sections. 
1.4.1.A. The Sec Pathway  
In bacteria, the major pathway of protein translocation from the cytoplasm to the 
periplasmic space is through the General Secretory (Sec) translocon (see Figure 1.6, 
[44]).  It is comprised of a motor domain, the ATPase of the SecA protein, and a 
membrane embedded channel consisting of proteins SecY, SecE and SecG [45].  
Polypeptides are secreted in a largely unfolded form, threading their way through the 
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SecYEG pore by SecA.  A Sec-specific chaperone, SecB recognizes the Sec signal 
sequence and targets the preprotein to the Sec pathway by its ability to bind SecA and 
maintain the polypeptide in an unfolded state [46].  SecA then feeds the polypeptide into 
the translocase through a repetitive ratchet-like motion [47], with approximately 20 
amino acids inserted into the pore per cycle of ATP until the polypeptide has been 
completely secreted [48, 49].  In the periplasm, the signal peptide is cleaved by signal 
peptidase I, and the protein folds on its own or with the help of periplasmic oxidases or 
isomerases. 
 
Figure 1.6. Model of the Sec pathway.  As shown, SecB recognizes the signal sequence and 
targets the polypeptide to SecA which then translocates the polypeptide through the SecYEG pore 
by expending ATP.  Figure adapted from [44]. 
 
Although the Sec pathway is used extensively for protein expression, it has some 
limitations.  When incompatible heterologous polypeptides insert into the SecYEG pore, 
they become stuck and are unable to translocate [50].  This effectively blocks the export 
of all native Sec proteins causing cell lysis.  In addition, some heterologous secreted 
proteins are toxic to the cell and also misfold in the periplasm rendering them inactive 
[51].  This is due to the fact that the periplasm lacks most of the ATP-dependent 
chaperones associated with the cytoplasm [52].  Finally, many enzymes require cofactors 
which need to be incorporated into the protein during folding.  Since the Sec pore is 
 15
narrow, the system can only transport unfolded proteins [53] so cofactor insertion cannot 
occur and therefore limits the types of recombinant enzymes which can be secreted by the 
Sec system [54]. 
1.4.1.B. The Tat Pathway  
The recently discovered Tat pathway is able to translocate fully folded proteins in 
their compact, native-like state across the inner membrane [55, 56].  With its discovery 
nearly ten years ago and the early evidence suggesting the pathway exports folded 
proteins [57], it appeared likely that the Tat pathway may be useful for potential 
engineering and production of proteins that cannot be transported across the inner 
membrane in an active form via the Sec pathway.  For example, green fluorescent protein 
(GFP) is nonfluorescent when exported to the periplasm through the Sec pathway [58], 
but GFP fusions that are exported through the Tat pathway have been shown to be 
fluorescent and capable of being used as molecular tags [59].  
Although only responsible for about 5-8% of secreted proteins in E. coli [60], 
most of these proteins are considered to require cofactor insertion [61], and the majority 
are cofactor-containing redox proteins [62, 63].  These cofactors are synthesized in the 
cytoplasm and are integrated into the protein during folding [63], making them 
incompatible with Sec transport.  Also, proteins requiring the assembly of multiple 
subunits in the cytoplasm can be exported by Tat [55].  The Tat pathway has been shown 
to export proteins with molecular weights up to 120 kDa [57].   
The Tat pathway is named for the invariant arginine residues in the N-terminal 
consensus motif, SRRXFLK, where X is any amino acid, of the Tat signal peptide [64].  
There are three domains in a signal peptide: a positively charged N-terminal domain, a 
hydrophobic domain, and the C-terminal domain.  The signal peptide is necessary to 
initiate export across the membrane in the majority of secretion systems [56].  Tat signal 
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peptides are approximately 14 amino acids longer, are significantly less hydrophobic in 
the middle of the signal, and are more positively charged at the end of the signal than Sec 
signal peptides [65, 66]. 
The Tat operon is comprised of five genes, tatA, tatB, tatC, tatD and tatE, but 
TatD has been shown to play no role in Tat pathway export [67], and tatE is a duplication 
of tatA [68].  Only the TatA, TatB and TatC proteins are necessary for Tat export, and 
these proteins contain at least one transmembrane helix which is a hydrophobic alpha 
helix that is inserted across the phospholipid bilayer of the inner membrane.  TatA and 
TatB are very similar in sequence and structure in that they contain an N-terminal 
transmembrane helix followed by a short hinge region and then an amphipathic helix [69] 
(see Figure 1.7, [70]).  Studies have shown that the TatB amphipathic helix is necessary 
for Tat transport [71], and that it contacts the entire signal peptide and some of the mature 
protein in vitro [72].  The transmembrane helix of TatA is required for interactions with 
TatB and export [71, 73].  TatC has six transmembrane helices and both the N- and C-
termini on the cytoplasmic of the inner membrane [74, 75] indicating that the cytoplasmic 
side of TatC is important for function.  It has been shown that signal peptides interact 
with TatC and that this interaction requires the twin-arginine motif of the Tat signal 





Figure 1.7. Predicted structure and topology of the E. coli Tat components.  Boxes represent 
helical regions.  Figure adapted from [70]. 
 
The current model of Tat translocation proposes that the Tat proteins remain as 
separate complexes and only come together to form a complete pore after substrate 
binding [72, 77].  This allows the formation of different size pores to match the folded 
Tat substrates which restricts the possibility of ion leakage through the pore while the 
substrate is being translocated (see Figure 1.8, [70]).  TatA is expressed by cells 
approximately 20 times more than TatB or TatC [78], indicating that TatA most likely 
forms the majority of the Tat pore [77, 79].  In addition, electron microscopy of a Tat 
complex showed pore-like structures comprised mainly of TatA that were blocked on the 
cytoplasmic side of the inner membrane [80].  Studies have shown that TatB and TatC 
form membrane complexes with multiple copies of each protein in equimolar amounts 
[81].  In addition, membrane complexes of TatA and TatB have also been purified along 
with complexes containing TatA, TatB, and TatC in which TatA is present in a large 
molar excess [82].  Most likely, the Tat signal peptide is recognized by Tat-specific 
chaperones which target the pre-protein to TatBC after folding and cofactor insertion 
which results in the recruitment of TatA to form the protein transport channel (see Figure 
1.8).  
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Transport through the Tat pathway is driven by the proton motive force across the 
membrane rather than ATP hydrolysis as in the Sec system [83].  The proton motive 
force is the sum of the electrical gradient due to the charge differential that exists across 
the membrane, and the chemical gradient caused by concentration differences on each 
side of the membrane [84].  The Sec system requires one ATP molecule per 20 amino 
acid residues that are translocated [49] while it has been calculated that the Tat pathway 
uses the energy equivalent of approximately 10,000 ATP molecules per protein [85].  
Thus, the Tat pathway is more energetically demanding which may be the reason so few 
proteins are Tat substrates.  
 
Figure 1.8. Model of Tat targeting and transport.  After translation, the signal peptide and 
binding of Tat-specific chaperones (maroon circles) aid the pre-protein to avoid being targeted to 
other pathways (a) such as Sec.  After folding and any necessary cofactor insertion or subunit 
association (b), the pre-protein is targeted to the TatBC complex (c).  The pore is formed by 
TatA, and translocation is driven by the proton motive force (d).  On the periplasmic side of the 
membrane, the signal peptide is removed, and the mature protein is released (e).  TatA, TatB, and 
TatC are shown in maroon, blue, and gold, respectively.  Figure adapted from [70]. 
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1.4.2 ClpXP and ClpAP Proteases 
Proteolysis plays a major role in the regulation of metabolic processes such as cell 
cycle control [86] and a cell’s response to environmental factors and DNA damage [87, 
88].  It is an irreversible mechanism that is energy dependent, and it is the main process 
by which cells degrade proteins that have spontaneously denatured, contain translation 
errors in the peptide chain or have accumulated mutations that interfere with the protein’s 
function [89, 90].  Also, by degrading key rate-limiting enzymes, a cell’s metabolic 
activities can be regulated [91].  Proteases are extremely important during stress 
responses to environmental factors during which many proteins become damaged [92].  
Therefore, proteases are typically induced during these stress responses to prevent the 
accumulation of abnormal protein.  In prokaryotes, the proteases ClpXP, ClpAP, Lon, 
HslUV and FtsH carry out the degradation of target proteins [93]. 
The serine-type ClpP protease from E. coli is one of the best characterized 
proteases, and the Clp (caseinolytic protease) proteins are well conserved throughout 
most prokaryotes and in some organelles of eukaryotes [94].  ClpA, an ATP-dependent 
chaperone, was the first protein of the Clp family to be isolated and was found to degrade 
casein when complexed with ClpP [95, 96].  ClpX was later identified as another ATP-
dependent chaperone similar to ClpA [97].  ClpP can only degrade small peptides as 
folded proteins must first be unfolded through ATP hydrolysis by ClpA or ClpX [98, 99]. 
1.4.2.A. The ClpP Serine Protease 
For both proteases, ClpP is the enzyme whose active proteolytic sites are within 
an internal cavity formed by two seven-subunit rings comprised of 14 identical subunits 
and are only accessible through narrow axial channels of approximately 50 angstroms in 
diameter [100-102] (see Figure 1.9A&B [89, 103]) .  Each of these subunits contain a 
catalytic triad composed of serine-histidine-aspartic acid residues and is only accessible 
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to small peptides or larger, unfolded proteins translocated by either chaperone, ClpX or 
ClpA [102].  The E. coli clpP gene encodes a protein of 207 amino acids although the 
first 14 residues are autolytically cleaved to yield a mature protein of 21.5 kDa [96].  This 
self-processing may serve as a regulatory mechanism since only the mature protein is 
active [104].  Recent work has shown that the N-terminal region of the ClpP subunits 
form flexible loops that may help it associate with either chaperone [105]. 
1.4.2.B. The ClpA and ClpX Chaperones 
In order to obtain full proteolytic activity, ClpP must associate with one of the 
two related ATPase subunits, ClpA or ClpX, both members of the AAA+ (ATPases 
Associated with diverse cellular Activities) superfamily of proteins.  ClpA and ClpX are 
both ATP-dependent chaperones which are composed of six subunits arranged in a 
hexagonal ring that can associate with either or both sides of ClpP, but recognize 
different degradation tags [104, 105] (see Figure 1.9C [103]).  ClpA and ClpX have the 
role of binding the target protein by recognizing a degradation tag [104], unfolding the 
protein and translocating the protein into the proteolytic chamber of ClpP [106, 107]. 
The two chaperones are very similar except that ClpA (84 kDa) has two ATPase 
domains while ClpX (46 kDa) only has one [97].  ClpX has been more widely studied 
and is comprised of three domains: an N-terminal domain containing a zinc binding 
domain [106], a central ATPase domain (or two for ClpA), and a C-terminal sensor and 
substrate discrimination (SSD) domain.  Although this SSD domain can interact with 
some substrates [107], it is more likely that the N-terminal domain is responsible for 
substrate specificity since this domain is similar to the I-domain of E. coli HslU which 
has been shown to be responsible for substrate specificity [108].  Studies have also shown 
that ClpX activity is not affected when the N-terminal domain is removed [109].  The 
ClpX C-terminal domain has been shown to contain a conserved isoleucine-glycine-
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phenylalanine (IGF) tripeptide which is located on an extended loop.  Six tripeptides 
from the ClpX hexamer make hydrophobic contacts with the ClpP heptmer [110] (see 
Figure 1.10 [111]).  Hexamerization occurs in the presence of ATP, Zn++ and Mg++ [106, 
109, 112] and forms the axial pore through which substrate proteins are threaded, 
unfolded and translocated into the pore of ClpP for degradation [113].  In addition to 
degradation, ClpA and ClpX can also act as independent chaperones in which they bind 
an unfolded protein to allow remodeling to occur such that upon release, the protein folds 




Figure 1.9. ClpP and ClpX representations.  A) Ribbon model of ClpP showing the two stacked 
heptameric rings; the bottom in yellow and the top as colored subunits.  B)  Spacefill model of 
ClpP looking down through the axial pore.  C) Spacefill model of ClpX also looking down 
through the axial pore.  Both spacefill models show each subunit as a different color. Figure 




Figure 1.10. Model for ClpP and ClpX interaction.  A) Spacefill model of ClpP and HslU 
indicating the possible interaction points.  HslU is an analog of ClpX and does not bind ClpP.  B) 
Cartoon showing how the hydrophobic pockets of ClpP may interact with the IGF loops of ClpX.  





Figure 1.11. Schematic showing the dual roles of the ATPase.  The ATPases, ClpX and ClpP are 
not only involved in substrate degradation.  They can also bind unfolded or incorrectly folded 
substrates, unfold them and release them so that they may attempt to fold correctly again.  Figure 
adapted from [103]. 
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1.4.2.C. Substrate Recognition 
Substrate recognition occurs through binding of either N- or C-terminal motifs 
intrinsic to the protein or through tags acquired after or during translation such as the 
SsrA protein tag [115].  These tags include three N-terminal and two C-terminal motifs 
identified from fifty ClpXP substrates [116] which include the plasmid P1 RepA and 
MuA transposase [117].  The motifs are comprised mostly of hydrophobic residues 
although one N-terminal motif contains polar residues.  Transferring these motifs to other 
proteins makes them substrate for hydrolysis by ClpX [116].  The motifs can be moved to 
other positions in the protein, but their placement at the either end of the protein is more 
favorable due to the accessibility of the ends to ClpX [118].  Other efforts have shown 
that some tags recognized by ClpX can also be recognized by ClpA in certain cases [119, 
120]. 
The SsrA tag of E. coli has the sequence of AANDENYALAA and is a 
hydrophobic tag that is grafted to proteins that are stalled in the ribosome during 
translation [121] (see Figure 1.12 [122]).  It is translated onto a protein by an RNA 
molecule that has both transfer RNA activity and an mRNA sequence.  When a ribosome 
stalls on a mRNA either due to amino acid starvation, rare codon usage or a lack of a stop 
codon [123], the alanine-charged-SsrA RNA enters the A site of the ribosome, causing 
the stalled polypeptide to be transpeptidated to the alanine and transferred to the SsrA 
RNA.  The mRNA in the SsrA is then translated by the ribosome, adding the tag to the 
end of the polypeptide chain and then releasing the protein to be degraded.  Thus, the 
function of the SsrA RNA and SsrA tag is to provide a method for the release of stalled 




Figure 1.12. Model of SsrA tagging of proteins.  An aminoacylated-SsrA RNA is recruited to a 
stalled ribosome which then transfers the polypeptide chain to its alanine-charged (yellow) tRNA 
domain.  The open reading frame within SsrA (magenta) is then translated until a stop codon is 
reached, and the tagged protein is released.  Figure adapted from [122]. 
1.4.2.D. Substrate Unfolding 
Previous studies have shown that degradation of SsrA-tagged substrates can be 
increased with the overexpression of SspB [124, 125], an adaptor protein that recognizes 
the SsrA tag and associates with ClpXP [126].  SspB has a substrate-binding domain that 
contacts the N-terminal residues of the SsrA tag and a C-terminal XB peptide motif that 
is involved in flexible tethering to ClpX [127] (see Figure 1.13 [127]).   Therefore, ClpX 
only contacts the C-terminal residues of the tag [128].  The SspB adaptor that recognizes 
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the tag then dimerizes with another SspB adaptor to deliver the tagged substrate to ClpX 
using the two XB peptide motifs to anchor the dimerized adaptor to ClpX.   
 
 
Figure 1.13. SspB binding and delivery of the SsrA tag.  A) SsrA tag bound by an SspB subunit 
and ClpX.  B)  Cartoon showing the tethering of the SspB dimer to ClpX by the XB peptide 
motifs on flexible peptide chains.  Figure adapted from [127]. 
 
In the currently proposed model, ClpA and ClpX apply mechanical force to the 
degradation tag causing the unfolding of the protein structure neighboring the tag [129, 
130].  For ClpX, this is accomplished by the interaction between the dimerized SspB 
adaptor protein and ClpX itself once the adaptor is tethered by its flexible polypeptide 
chains (see Figure 1.14 [131]).  ATP hydrolysis causes ClpX to apply a pulling force on 
the SsrA tag and the protein.  However, this usually results in the release of the tag 
indicating that ATP is not used efficiently [131, 132].  The result is that either SspB 
attempts to feed the tag again into ClpX or disassociates completely.  If the tag does not 
slip, the SspB dimer disengages from ClpX as more of the tag is pulled into ClpX, thus 
forcing SspB to release its recognized part of the tag.  This release and reengagement 
mechanism prevents ClpX from being stalled on very stable substrates thereby making 




Figure 1.14. Model of the mechanistic action of ClpX.  After the SspB dimer associates with 
ClpX, ATP hydrolysis causes ClpX to apply a force to the tag, straining its association with the 
dimer.  This can cause slippage in which the dimer can retry or dissociate.  If no slippage occurs, 
the tag is pulled into ClpX causing the release of the dimer.  Shown is a substrate that was 
disulfide-linked to the dimer specifically for this research study.  Figure adapted from [131]. 
 
Recent work has shown that there are three alpha-helical loops in the axial pore of 
ClpA that are involved in binding the SsrA tag and unfolded polypeptide chains [134].  
Two loops are located at what is called the D1 ATPase domain, while the third is near the 
D2 ATPase domain [135].  For unfolding to occur, the tagged protein is held in the N-
terminal domains of ClpA such that the tag extends axially down through the pore (see 
Figure 1.15 [134]).  In this manner, the tag is held in place by the loops in D1 and can 
contact the loop in D2.  The binding sites of the three loops is still unknown, but is has 
been proposed that they may form a shallow grove to bind the SsrA tag similar to SspB 
[136].  Upon ATP hydrolysis by the D2 ATPase, the D2 loop moves to a distal position 
 27
in the channel, thereby applying a mechanical force on the tag and unfolds the substrate 
while simultaneously translocating the polypeptide chain into the pore.  The loops at D1 
may provide a means to keep the unfolded chain from slipping while the D2 loop cycles 
back to a proximal position to bind the polypeptide chain again due to evidence that ClpA 
recognizes unfolded substrates without a tag element [137].  As seen with ClpX, multiple 
rounds of ATP hydrolysis are necessary to unfold the tagged substrate [98]. 
 
 
Figure 1.15. Model of the mechanistic action of ClpA.  The SsrA tag (red) interacts with the 
three loops of ClpA, two at the D1 ATPase and one at the D2 ATPase.  The tagged protein 
(green) is held in place by the N-terminal domains of ClpA.  ATP hydrolysis by the D2 ATPase 
moves the D2 loop distally, applying a mechanical force that translocates the polypeptide chain 
and unfolds the substrate.  After the D2 loop cycles, further rounds of binding, translocation and 
unfolding can occur with the hydrolysis of ATP.  Figure adapted from [134]. 
 
1.4.2.E. Substrate Proteolysis 
The proteolytic complex is typically comprised of one subunit of ClpA or ClpX 
per subunit of ClpP.  Since the optimal ratio of ClpA or ClpX to ClpP is two to one [90], 
two units of either chaperone may bind to both ends of ClpP [138].  However, once a 
substrate begins translocation into ClpP, the ClpA or ClpX subunits bound to the either 
face will dissociate so as not to inhibit the translocation [139].  The affinity of ClpA for 
ClpP is about twice that of ClpX [113], but due to conformational changes in the IGF 
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loops of ClpX upon substrate binding, the affinity of ClpX to ClpP increases significantly 
[140]. 
In either case, after the protein is unfolded by ClpX or ClpA, the small linearized 
piece of protein is then axially fed into ClpP, and ClpA or ClpX unfolds more of the 
protein, repeating the cycle [139] to degrade the protein into peptides of seven to ten 
amino acids without any sequence specificity [104].  This tight distribution of degraded 
pieces occurs since translocation by the chaperone alternates with degradation by ClpP  
through some yet to be determined means of communication between the chaperone and 
ClpP [141]. 
ATP requirements for protein unfolding and degradation depend typically on how 
stable the substrate’s terminus is adjacent to the tag [132].  Thus, proteins with less 
structure are easier to degrade.  For example, research on another protease has shown that 
proteins with intermolecular disulfide bonds are degraded an order of magnitude slower, 
but typically, different variants of the same protein only vary over a two-fold rate range 
[142]. 
Three models have arisen from previous work to explain how the ClpA and ClpX 
ATPase motors function [143, 144].  In some studies dealing with ATPase motors similar 
to those of the Clp system, several motor structures have been isolated with ATP bound 
to all of the subunits [145, 146].  This indicates that each subunit of the Clp ATPases 
hydrolyzes ATP simultaneously to function as a concerted mechanism (see Figure 1.16 
[147]).  However, other studies show structures with ATP bound to only some of the 
subunits [148].  From these studies a sequential mechanism has been proposed in which 
the subunits hydrolyze ATP one at a time in a predetermined, sequential order around the 
hexamer ring.  Similarly, the final model proposes that each subunit hydrolyzes ATP 
individually but not in any special order [144].  Developers of the model indicate that 
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since each part of a substrate is conformationally different and therefore can contact any 
subunit in the hexamer ring, certain subunits can only interact with the substrate at a 
given time.  The subunit with the most or the best interaction may be the one that 
hydrolyzes ATP and further unfolds and translocates the substrate.  Sauer and coworkers 
constructed a ClpX hexamer with only one functioning subunit which still was able to 
unfold and translocate proteins and used many combinations of active and inactive 
subunits in the hexamer to  show that the rate of ATP hydrolysis was proportional to the 
number of active subunits [144].  Therefore, the final model seems to be the most likely 




Figure 1.16. Proposed models of Clp ATPase motor function.  A typical hexamer is shown and 
the subunit hydrolyzing ATP is shaded.  The sequential model shows that one subunit hydrolyzes 
ATP in order around the ring.  The concerted model proposes that all subunits hydrolyze 
simultaneously.  The probabilistic model indicates that one subunit functions individually in no 
specified order.  Figure adapted from [147]. 
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1.5 STATE OF THE ART 
1.5.1 Biotechnology and the Tat Pathway 
As described above, production of recombinant proteins is typically done in 
bacteria, i.e. E. coli, since they can be grown quickly, inexpensively and can be used to 
express a variety of proteins.  Expression of proteins in the cytoplasm allows the protein 
to take advantage of the molecular chaperones, cofactors, and foldases present in the 
cytoplasm, if necessary, to ensure proper folding.  However, export of folded proteins 
into the periplasm via the Tat pathway could improve yields, reduce further downstream 
processing that would be required to remove cytoplasmic components and could be 
exploited for protein display purposes in the engineering of proteins with new or 
improved function. 
However, two obstacles must be overcome in order to utilize the Tat pathway for 
protein production.  First, some therapeutic proteins contain disulfide bonds which are 
necessary for proper folding and can only form in an oxidizing environment.  This 
problem has been solved by the use of a strain of E. coli that has been engineered to have 
an oxidizing cytoplasm.  Previous work has shown that disulfide-containing proteins can 
be exported by the Tat pathway in this oxidizing strain [55].  A recent study showed that 
export of a variable form of tissue plasminogen activator which contains nine disulfide 
bonds through the Tat pathway in the oxidizing strain yields higher amounts of active 
enzyme in the periplasm compared to export through the Sec pathway [149]. 
 The second and more important barrier to using the Tat pathway for protein 
production is the fact that efficiency [150] and protein yields through the Tat pathway are 
much lower than those through the Sec pathway, which, for antibody fragments, typically 
exceed 1 g/L [151, 152].  This may be due to the fact that the export machinery can be 
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saturated by overexpressed target proteins which occurs for even native Tat export 
proteins [153, 154].  The saturation of the export machinery can be partially relieved by 
co-expression of other proteins [154, 155], however, it may also be necessary to engineer 
the protein to fold or interact better with the Tat export machinery or overexpress some or 
all of the Tat proteins in order to increase periplasmic yields. 
 Besides the benefit of export to the periplasm, the Tat pathway also offers a 
quality control advantage in that it exports only correctly folded proteins [55].  This is 
especially important for antibody fragment production since the Tat pathway will ensure 
that only correctly folded fragments in which disulfide bond formation has occurred is 
transported to the periplasm.   
 
1.5.2 Engineering Protein Stability 
 Due to the increased use of enzymes in industrial processes, many of these 
biocatalysts have to be engineered with improved properties [156].  Many factors affect 
the stability of these enzymes such as the use of surfactants and solvents, pH,  
temperature and oxidative stress [157].  Many enzymes unfold and become inactivated at 
high temperatures, and therefore, thermostability is widely studied since the majority of 
industrial processes operate at high temperatures in order to maintain solubility, achieve 
high conversion rates, etc [1]. 
 Several methods have been used to engineer enzymes with higher temperature 
stabilities.  For example, the introduction of internal disulfide bonds dramatically 
stabilizes the protein against unfolding [158, 159].  In other studies, stability was 
increased by helix optimization whereby residues were changed to increase the 
propensity of alpha helix formation [160] and allow better interaction between 
neighboring alpha helices [161].  Localized residues that form salt bridges were also 
shown to increase the stability [162].  Finally, aromatic residues that extend from the 
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protein can interact if in close proximity.  This “aromatic stacking” has been shown to 
also increase a protein’s stability [163]. 
 As indicated, there are several methods to engineer a protein for increased 
stability, however, none deals with increasing a protein’s stability to mechanical 
unfolding.  A protein used in flow conditions, such as in arteries may encounter a shear 
stress that would strain a protein’s conformation.  Studies have been conducted to 
determine a protein’s stability to mechanical unfolding and will be discussed in Chapter 4 
as they specifically apply to research aimed at capitalizing on the mechanism of 




1.6 RESEARCH OBJECTIVES 
 Unless only a few specific changes are made to a protein to increase stability or 
export, a high-throughput screening method must be used to explore many combinations 
of multiple and/or simultaneous changes.  High-throughput screening via cell display 
allows the linkage of genotype to phenotype required by directed evolution and the rapid 
measurement and screening of phenotypes from mutant libraries. 
 The recently discovered Tat system allows the export of fully-folded proteins 
across the inner cell membrane.  Previously, secreted proteins were required to fold in the 
periplasmic space after export thus limiting the number of recombinant proteins that 
could be produced in E. coli to those that only fold correctly in the periplasm.  The Tat 
system now allows protein engineers to take advantage of the available protein folding 
machinery in the cytoplasm, increasing the number of recombinant proteins that can be 
produced in bacteria.  However, since efficiency and yield is generally low, we sought to 
examine the effect of mutations within the mature protein on the efficiency of export via 
the Tat apparatus in order to increase protein yield in the periplasm.  Directed evolution 
and FACS was used to increase export of 26-10 scFv in an oxidizing strain of E. coli.  
The 26-10 antibody binds digoxin, a cardiac glycoside that regulates electrical impulses 
in the heart and the strength of contractions.  One isolated clone showed increased export 
of 26-10 to the periplasm.  In vitro analysis of the thermodynamic stability and folding 
kinetics indicated that the mutant scFv exhibits faster folding kinetics, and this is likely to 
be responsible for the improved export to the periplasmic space.  This work is described 
in Chapter 2. 
In addition, in order further increase the export of the 26-10 scFv through the Tat 
pathway, Chapter 3 describes work dealing with the co-expression of certain chaperone 
and Tat translocon proteins that were previously shown to relieve some saturation of the 
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Tat pathway.  The effect of media, pH and temperature and the use of different oxidizing 
strains of E. coli on cell fluorescence and growth were also investigated.   
Finally, I have used flow cytometry in an attempt to develop a genetic system for 
the better understanding of the Clp system and for studying how amino acid substitutions 
might affect the mechanical stability of protein substrates.  It was proposed that since the 
Clp system degrades proteins, finding ways to inhibit the system would increase the 
yields of recombinant proteins produced in E. coli.  In addition, since the system applies a 
mechanical force to unfold proteins, the Clp system could be used as an assay to engineer 
more stable proteins against mechanical denaturation.  In order to accomplish this, GFP 
tagged with the SsrA peptide was used as a fluorescent reporter to develop an appropriate 
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Engineering Proteins to Increase Tat Export Efficiency 
 
2.1 INTRODUCTION 
As described in the first chapter, the conformation of proteins in the cytoplasm is 
a critical element in determining their competence for translocation across lipid bilayer 
membranes.  In E. coli, proteins that are exported via the general secretory pathway must 
be maintained in a partially unfolded conformation that can be threaded via the narrow 
pore of the SecYEG translocation apparatus [1-3].  For some proteins, this is not a 
problem because they are synthesized co-translationally by ribosomes that dock onto the 
membrane via the interaction of the signal recognition particle with its receptor [4].   
However, for the majority of proteins that utilize the general secretory pathway, 
membrane translocation occurs post-translationally.  Export competence is ensured by 
interactions with chaperones such as SecB and by the signal peptide which serves to 
retard folding [5-8].  Proteins that fold too rapidly to benefit from these processes are 
incompetent for export and remain in the cytoplasm.  Consistent with this idea, a recent 
genetic selection for mutants of the fast folding cytoplasmic protein thioredoxin, which is 
not compatible for export when fused to the signal peptide of a post-translationally 
exported protein, resulted in the isolation of slower folding variants [9].   
In sharp contrast to export via the SecYEG pore, proteins that utilize the post-
translational Tat secretion pathway have to be folded in order to be competent for export 
[10].  Misfolded or partially folded proteins cannot be translocated via the Tat pathway, 
suggesting the existence of a folding quality control mechanism that operates either prior 
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to, or concomitant with, translocation through the Tat pore [11, 12].  Not surprisingly 
polypeptides prone to aggregation cannot be exported to the periplasm via the Tat 
pathway.  Recently, Fisher et al. showed that tripartite fusions comprising of: (i) the Tat 
specific signal peptide ssTorA; (ii) variants of the amyloid peptide Aβ42 and (iii) the 
reporter protein β-lactamase could be localized in the periplasm and confer resistance to 
β-lactam antibiotics only if the Aβ42 moiety was soluble [13].  Mutations that increased 
the solubility of the Aβ42 peptide domain of the tripartite fusion allowed better Tat 
export and therefore resulted in higher resistance to antibiotics.   
The notion that unfolded proteins cannot be translocated via the Tat pathway is 
supported by in vivo and in vitro evidence from bacteria and from plant thylakoids [14-
19].  However, the relationship between the in vitro folding properties of a protein and 
competence for Tat export has not been investigated.   Processes that are dictated by the 
folding kinetics, such as of off-pathway reactions leading to the formation of aggregates 
or interactions with chaperones, are known to be important for protein translocation [20, 
21].   
In this study, we sought to examine the effect of mutations within the mature 
protein on the efficiency of export via the Tat apparatus in order to increase protein yield 
in the periplasm.  scFv antibody fragments comprised of the VH and the VL 
immunoglobulin domains linked by a (Gly4Ser)3 are widely used for biotechnology 
applications, and their folding characteristics have been studied in detail [22-24].  The 
26-10 scFv antibody fragment binds to digoxin and to other cardiac glycosides that 
regulate electrical impulses in the heart and the strength of contractions with nanomolar 
affinity [25, 26].  By using a fluorescently labeled derivative of digoxin and PECS 
(described in Chapter 1), high-throughput sorting was carried out on mutant libraries of 
the 26-10 scFv to isolate clones with increased fluorescence.  One isolated clone with 
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approximately twice the fluorescence of wild type (WT) 26-10 scFv showed increased 
export of 26-10 to the periplasm.  In vitro analysis of the thermodynamic stability and 
folding kinetics indicated that the mutant scFv exhibits faster folding kinetics.  The faster 
folding rate is likely to be responsible for the improved export to the periplasmic space. 
Special thanks to Thomas Van Blarcom for help with sorting by MoFlow, 
Christian Cobaugh and Mark Gebhard for help with BIACore experiments and Clint 








2.2 MATERIALS AND METHODS 
2.2.1 Strains and plasmids 
The bacterial strains and plasmids used in this study are listed in Table 2.1.  E. 
coli XL1-Blue cells were used for plasmid propagation. 
To construct the p99PelB-2610 pTrc99A plasmid, primers PelB.f, which contains 
the whole pelB signal peptide, and PelB.r were used to amplify the 26-10 gene from 
p99TorA-2610 by PCR.  The PCR fragment was digested with BsphI and XmaI and 
empty pTrc99A plasmid was digested by NcoI and XmaI.  Since BsphI and NcoI leave the 
same sticky ends of DNA upon cleavage, ligation of the PCR fragment and the digested 
pTrc99A plasmid forms the p99PelB-2610 construct. 
Using primers 14B7.f and 14B7.r and p99-14B7 as template, the 14B7 gene was 
amplified by PCR.  p99TorA-2610 and p99PelB-2610 DNA was digested with NheI and 
then treated with calf intestinal alkaline phosphatase (CIAP) to prevent the digested 
plasmid backbone from ligating to itself during the ligation step.  The PCR products were 
also digested with NheI and then ligated into both digested plasmids separately, creating 
p99TorA-14B7 and p99PelB-14B7. 
The pTorA-2610 pBAD18 scFv fusion was cloned using overlap extension PCR 
with primer sets T2610-1 to T2610-3.  Primers T2610-2.f and T2610-2.r in the overlap 
PCR changed a NheI restriction site after the torA signal peptide to an XbaI restriction 
site and primers T2610-3.f and T2610-3.r removed an XbaI restriction site internal to 26-
10 with a silent mutation.  p99TorA-2610 was used as the template in the reactions.  The 
fragment was then inserted into pBAD18 using the XmaI and SphI restriction sites.  
Primers P2610.f and P2610.r were used with p99PelB-2610 as template to clone the pelB 
signal into the pTorA-2610 construct using the XmaI and XbaI restriction sites making 
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pPelB-2610.  In the same manner, the P2610 primers were used to clone the pelB signal 
into the pTorA-2610C8 mutant clone creating pPelB-2610C8. 
 
Table 2.1. Strains, plasmids, and primers used in this study 
E. coli Strain 
or Plasmid Relevant Genotype or Features Source 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' proAB laclq Z∆M15 Tn10 (Tetr)] Lab collection 
DHB4 MC4100 phoR ∆(phoA ) PvuII ∆(malF)3 F' [lacIqZYA -pro] Lab collection 
FA113 DHB4 trxB gor552 Tn10tetr ahpC* J. Beckwith 
FA113 ∆tatC DHB4 trxB gor552 Tn10tetr ahpC* tatC::spec Lab collection 
pBAD18 araBAD promoter, pBR322 ori, cmr Ref. [27] 
pTrc99A trc promoter, ColE1 ori, cm
r Amersham 
Biosciences 
p99-14B7 14B7 in Trc99A Lab collection 
p99TorA-
2610 
ssTorA-26-10 in pTrc99A Lab collection 
p99TorA-  
14B7 
ssTorA-14B7 in pTrc99A This study 
pTorA-2610 ssTorA-26-10 in pBAD18 This study 
pTorA-2610C8 ssTorA-26-10 mutant C8 in pBAD18 isolated from library This study 
p99PelB-2610 ssPelB-26-10 in pTrc99A This study 
p99PelB-
14B7 
ssPelB-14B7 in pTrc99A This study 
pPelB-2610 ssPelB-26-10 in pBAD18 This study 
pPelB-2610C8 ssPelB-26-10 mutant C8 in pBAD18 This study 
Primers     
PelB.f GTCTTCATGAAATACCTATTGCCTACGGCAGCCGCTGGATTGTTATTACTCGC
GGCCCAGCCGGCCATGGCCGCTAGCGAAGTTCAACTGCAA 
PelB.r CCTAGCCCGGGTCAGTGGTGGTGGTGGTG  
14B7.f ATATGCTAGCGATATTCAGATGACACAGACT 















2.2.2 Growth conditions, expression, PECS and purification 
Unless otherwise noted, cells were grown at 37oC on LB media with 25 µg/ml 
chloramphenicol, 25 µg/ml kanamycin and/or 100 µg/ml ampicillian, as appropriate. 
Cells were grown in TB media containing the appropriate antibiotics at 37oC to an 
OD600 of approximately 0.3, and protein synthesis was induced by adding arabinose 
and/or IPTG to a final concentration of 0.2% and 0.1 mM, respectively.  Cultures were 
grown for an additional 4 hours at 30oC at which point 0.1 ml aliquots were taken for 
membrane permeabilization, labeling and FACS sorting per the procedure described 
previously [28].  For labeling, cells were mixed with 0.9 ml 5xPBS (phosphate buffered 
saline) containing 200 nM digoxigenin-BODIPY (4,4-difluoro-5,7-dimethyl-4-bora-
3a,4a-diaza-s-indacene-3-propionyl ethylenediamine) [29] (Molecular Probes).  The 
samples were incubated at room temperature for one hour with shaking, and the cells 
were pelleted at 2,000 g and resuspended in 1 ml of 5xPBS before being analyzed by 
flow cytometry.  Flow cytometry was carried out on a Becton-Dickinson FACSort flow 
cytometer with the following settings in log format: Forward scatter E01, Side scatter 
trigger 350 volts, FL-1 700 volts, FL-2 700 volts. 5xPBS was run as sheath for all scans.  
Fluorescence was monitored by 488 nm emission via a 530/30 band-pass filter (FL-1).   
Colonies isolated following sorting were picked to individual wells of a 96-well 
plate (Costar brand round bottom, polystyrene, non-binding surface) containing 100 µl of 
TB media with the appropriate antibiotics.  After overnight growth at 37oC, fresh 
microtiter well plates were inoculated, the cells were grown for 1.5 hours at 37oC, and 
induced by the addition of arabinose to a final concentration of 0.2%, respectively.  
Cultures were then grown at 30oC for an additional four hours.  Subsequently, the cells 
were pelleted by centrifugation at 2,000 g for ten minutes at room temperature.  The cells 
in each well were resuspended in 200 µl of 5xPBS containing 200 nM digoxigenin-
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BODIPY and incubated for one hour at room temperature.  The plates were centrifuged 
again at 2,000 g for ten minutes at room temperature.  200 µl of 5xPBS was added to 
each well to resuspend the cells before the plate was analyzed by a BioTek Synergy™ 
HT Microplate Reader using an excitation filter of 480 nm and an emission filter of 530 
nm.  To confirm fluorescence readings, 5 µl of sample from a well was added to 1 ml of 
5xPBS in a sieve tube to be analyzed by flow cytometry. 
For mid-scale expression and purification [28, 30], 40 ml cultures were grown 
overnight in TB media at 37oC.  These cultures were added to 460 ml fresh TB media and 
grown until mid-log phase and induced with arabinose to 0.2% final concentration.  
Incubation was continued for four hours at 30oC, and the cells were harvested by 
centrifugation at 4,000 g for 10 min at 4oC.  The cell paste was resuspended in 10 ml of 
10 mM Tris, 0.75 M sucrose, pH 7.5.  1 ml of lysozyme was added, and the cells were 
swirled on ice for 20 minutes.  20 ml of 1 mM ethylenediaminetetraacetic acid (EDTA) 
was added slowly, and the cells were left to swirl for another 15 minutes.  1.4 ml of 0.5 
M MgCl2 was added and another 15 minutes of swirling elapsed.  The resulting 
spheroplasts were then pelleted at 10,000 g for 15 minutes at 4oC. 
0.5 ml of Ni-NTA agarose resin (Qiagen) was washed repeatedly in 1xIMAC 
buffer (0.02 M Na2HPO4, 500 mM NaCl, 0.1 M imidazole, 0.1% Tween-20, pH 7.5) to 
remove the ethanol storage solution.  The supernatant was decanted after centrifugation, 
and 3.5 ml of 10xIMAC buffer was added along with the Ni-NTA agarose.  After shaking 
on ice for one hour, the resin was pelleted at 3,000 g for 5 minutes at 4oC.  The resin was 
washed twice with 50 ml of 1xIMAC buffer with centrifugation in between washes.  5 ml 
of the last wash was kept with the resin and loaded onto a BioRad polyprep disposable 
column to drain.  1 ml of 1 M imidazole in 1xIMAC buffer was added to the column and 
left for five minutes before collecting the eluate.  The collected eluate was injected into 
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an Äkta FPLC system (Amersham Pharmacia) using a Superdex 200 HR10/30 column 
(Amersham Pharmacia).   Fractions (0.5 ml) corresponding to the molecular weight of the 
scFv (as determined by running protein standards) were collected, concentrated using 
Amicon Ultra Cellulose filters (Millipore), and quantified by bicinchoninic acid assay 
(Pierce) using BSA as a standard and SDS-PAGE with known molecular standards. 
2.2.3 Library construction and sorting 
Primers E2610.f and E2610.r were used with pTorA-2610 as template for error-
prone PCR [31] to create a library with approximately 13 mutations in the 26-10 scFv 
gene corresponding to a mutation rate of 1.3% determined by sequencing six clones from 
the library.  The PCR were inserted into the pTorA-2610 plasmid using the XbaI and 
XhoI restriction sites.  The ligation mixture was electroporated into E. coli XL1-Blue 
cells and plated on antibiotic containing plates.  Plasmid was isolated from the resulting 
colonies by QIAprep Spin Miniprep Kit (Qiagen).  The isolated plasmids were then used 
to transform the library into the FA113 strain resulting in 6x106 transformants.  
1 ml of frozen stock of library cells was used to inoculate 100 ml of TB media 
supplemented with 25 µg/ml chloramphenicol.  After growth for 1 hour at 37oC, 
expression of the 26-10 scFv was induced with arabinose to a final concentration of 
0.2%.  Growth was continued for four hours at 30oC.  100 µl of cells were labeled as 
above.  The library was then sorted on a MoFlo flow cytometer (FC) equipped with an 
Innova 90C argon laser (Cytomation, Fort Collins, CO).  Triggering on side scatter was 
set to 488 nm light from the argon laser.  Detection of digoxigenin-BODIPY binding was 
monitored by 518 nm emission via a 530/40 band-pass filter (FL-1).  By gating for cells 
showing high FL-1 signal, the library of scFvs was subjected to three rounds of sorting.  
Between each round of sorting, the collected events were subject to colony PCR 
amplification using primers E2610.f and E2610.r and reinserted into the pTorA-2610 
 52
construct using the XbaI and XhoI restriction sites.  Clones isolated after round 3 
selection were picked to 96-well plates, scanned by fluorescent plate reader and checked 
by flow cytometry.   
2.2.4 Biochemical Assays 
Cell fractionations were performed by the cold osmotic shock procedure, as 
described previously [11].  Briefly, cells were harvested by centrifugation at 2,000 g and 
resuspended in 1 ml fractionation buffer (30 mM Tris-HCl pH 8.0, 20% w/v sucrose, 1 
mM ethylenediaminetetraacetic acid, EDTA) per 10 ml of culture.  After ten minutes at 
25oC, the cells were centrifuged at 6,000 g for 15 minutes at 4oC.  The pellet was 
resuspended in 1 ml of ice cold 5 mM MgSO4 ice cold and left on ice for 5-10 minutes.  
After centrifugation at 16,100 g for 15 minutes at 4oC, the supernatant was kept as the 
periplasmic fraction.  The cell pellet was resuspended in 266 µl of 1xPBS, sonicated for 
30 s, and recentrifuged at 16,100 g for 15 minutes at 4oC to obtain the soluble 
cytoplasmic fraction and remove insoluble cell debris.   
Western blotting was performed as previously described in Chapter 2. The 
primary antibody was a monoclonal mouse anti-polyhistidine peroxidase conjugate 
(Sigma) diluted 1:10,000.  Western blots were also probed with anti-GroEL antibody 
(Sigma) as a control.   
Enzyme-linked immunosorbent assays (ELISA) were performed as previously 
described [32].  Digoxigenin-BSA (bovine serum albumin) at 2 µg/ml was used to coat 
the plates, and each ELISA was conducted on 100 µl of periplasmic fraction.  The 
monoclonal mouse anti-polyhistidine peroxidase conjugate (Sigma) was used to detect 
protein binding at a dilution of 1:3,000.  o-phenylenediamine tablets were used to 
develop the signal, and the reaction was stopped with H2SO4 before the plates were read 
at 490 nm on a Beckman BioMek plate reader. 
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2.2.5 Protein Characterization 
BIACore analysis was performed as previously described [33] using a BIACore 
3000 instrument.  Briefly, a CM-5 carboxymethylated dextran matrix chip (BIACore) 
was used for the immobilization of digoxigenin-BSA (approximately 130 RU, relative 
units) following the standard protocol from Pharmacia Biosensor.  All kinetics 
experiments were performed in HEPES-EP buffer containing 150 mM NaCl, 10 mM 
HEPES, 3.4 mM EDTA, and 0.005% polysorbate-20, pH 7.4 at 25°C with a flow rate of 
100 µl/min.  scFv proteins in the concentration range of 0.5 to 500 nM were added to the 
chip for the association rate measurements.  Regeneration of the antibody-bound chip 
was accomplished by using 50% ethylene glycol/HEPES-EP, pH 10.  BIAEvaluation 
software from Pharmacia Biosensor was used to calculate the association and dissociation 
rate values of the scFvs.  
Guanidine HCl (GdnHCl)-induced denaturation equilibrium experiments were 
carried out in degassed and sterile-filtered BBS (50 mM sodium borate, 150 mM sodium 
chloride) at 20oC at a final protein concentration of 15 µg/ml.  15 mM dithiothreitol 
(DTT) was added to keep the protein reduced when necessary.  Excitation wavelength 
was 280 nm, and the emission spectrum of the protein was scanned from 320 nm to 370 
nm using an AMINCO-Bowman Series 2 Luminescence Spectrometer.  Three spectra 
were averaged per sample, and the fraction of unfolded protein was calculated as 
described previously [34] by using the maxima at 360 nm. 
For renaturation kinetics, proteins were first denatured overnight at 20oC in BBS 
containing 80 mM DTT and 5.0 M GdnHCl.  The samples were then diluted to 0.5 M 
GdnHCl using BBS to a final protein concentration of 15 µg / ml, and the time-course for 
folding was measured by following the increase in fluorescence at 325 nm with excitation 
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at 275 nm.  Data points represented the average of four separate experiments.  Fitted 
curves were used to determine the macroscopic rate constants. 
For aggregation measurements of scFvs by light scattering, proteins at a final 
concentration of 15 µg / ml were incubated in different concentrations of GdnHCl for 16 
hours at 20oC, and the light scattering signal was monitored at 350 nm with emission at 













2.3.1 26-10 can be exported by the Tat pathway 
Previously, our laboratory had reported that the 26-10 scFv can be exported into 
the periplasmic space by fusion to the Tat specific signal peptide ssTorA from the E. coli 
trimethylamine N-oxide reductase [11].  Export was observed when the ssTorA-26-10 
scFv gene fusion was expressed only in E. coli strains that have an oxidizing cytoplasm, 
such a FA113 (trxB gor ahpC*).  Expression in trxB gor mutant strains allows the 
formation of the two disulfide bonds in scFv that are important for the stability of the 
protein [11, 35, 36].  The trxB gene of E. coli encodes for thioredoxin reductase which 
functions to maintain the reducing nature of the cytoplasm.  Similarly the gor gene 
encodes for the glutathione reductase enzyme which reduces glutathiones, in turn, 
required for the action of glutaredoxins.  The reduced forms of thioredoxins and 
glutathiones maintain the reducing nature of the cytoplasm by reducing disulfide bonds in 
cytoplasmic proteins. 
The amount of 26-10 scFv in the periplasm could be monitored by flow cytometry 
following partial permeabilization of the outer membrane by exposure to hypertonic 
buffer (5xPBS) and incubation with the fluorescent hapten digoxigenin-BODIPY.  Under 
these conditions, the fluorescent hapten diffuses readily across the outer membrane while 
the much larger antibody fragment cannot escape from the periplasm (see Figure 2.1).  
Binding of the hapten by the scFv in the periplasm results in higher cell fluorescence.  
Figure 2.2 shows that the cell fluorescence of E. coli FA113 expressing the ssTorA-26-10 
scFv fusion was approximately 3 times higher than the background cell autofluorescence 
in cells that do not contain plasmid.  Inactivation of the Tat export pathway by deletion of 
the essential Tat translocon component tatC resulted in low cell fluorescence.  Similarly, 
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background fluorescence was detected in the isogenic parental strain E. coli DHB4 where 
the oxidative folding of the scFv in the cytoplasm is prevented, and therefore the 
antibody fragment is incompetent for Tat export.  Since only background fluorescence 
occurs in strains containing pTorA-14B7, a scFv of unrelated specificity (the 14B7 scFv 
recognizes the PA antigen from Bacillus anthracis), non-specific binding of the 




Figure 2.1. Schematic showing the detection of periplasmic scFv antibodies via binding to 





Figure 2.2. Flow cytometric analysis of ssTorA-26-10.  E. coli strains DHB4, FA113 and FA113 
∆tatC are shown along with strain FA113 containing empty pBAD18 plasmid as a control.  Cell 
populations with indicated fluorescence intensities are represented as histograms. m, geometric 
mean cell fluorescence intensity. 
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The amount of 26-10 scFv protein in the cytoplasmic and periplasmic fractions 
was evaluated by Western blotting following cell fractionation using the osmotic shock 
procedure [11, 32].  The 26-10 scFv protein was detected using an anti-hexahistidine 
monoclonal antibody that recognizes the C-terminal His6 tag.  Consistent with the FACS 
analysis, the scFv protein could be detected in the periplasmic fraction from E. coli 
FA113 cells but not in E. coli DHB4 or FA113 ∆tatC (see Figure 2.3).  In E. coli FA113 
cells, the intensity of the antibody fragment band in the periplasmic fraction was only 
about 20-25% of the amount found in the cytoplasm indicating that export via Tat was 
inefficient.  Accumulation of precursor protein in the cytoplasm is frequently observed 
when authentic Tat substrate proteins or fusions to Tat signal peptides are expressed from 




Figure 2.3. Western blot of cell fractions.  Cell fractions from E. coli DHB4, FA113 and FA113 
∆tatC expressing ssTorA-26-10 scFv were performed by the cold osmotic shock procedure.  
Western blots were also probed with anti-GroEL antibody to show that cytoplasmic leakage did 
not occur.  Amounts corresponding to equal number of cells were loaded in each lane, and results 
were reproducible when repeated with duplicate cultures. 
 
2.3.2 Library screening 
The fact that the amount of the 26-10 scFv in the periplasm can be monitored 
quantitatively by flow cytometry was exploited to screen for mutations that enhance 
export via the Tat pathway.  By detecting the digoxigenin-BODIPY fluorescence, the 
amount of periplasmic scFv within each cell is determined directly in the absence of 
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reporter proteins that can otherwise dominate the solubility and folding kinetics of protein 
fusions [13, 41, 42]. 
The 26-10 scFv gene was subjected to random mutagenesis by error prone PCR 
[31] to give a library of 6x106 independent transformants.  Sequencing of six clones 
picked at random revealed an average of 13 nucleotide substitutions per gene which 
corresponds to a 1.3% error rate.  The library cell population was labeled by incubation 
with 200 nM digoxigenin-BODIPY, and fluorescence was analyzed by flow cytometry.   
As expected, the library displayed a lower mean fluorescence than cells expressing 26-10 
scFv since the majority of random mutations are deleterious for function [43] (see Figure 
2.4).  Clones exhibiting higher cell fluorescence were isolated by FACS.  To facilitate the 
isolation of antibody variants that accumulate at a higher level in the periplasm, rather 
than mutants exhibiting higher hapten affinity, cell labeling was carried out using 200 nM 
digoxigenin-BODIPY, a concentration significantly higher than the 2.3 nM KD of the 26-
10 scFv antibody for digoxigenin [33].  107 cells were sorted and the 0.3% most 
fluorescent events were collected.   Because incubation in 5xPBS, which is required for 
outer membrane permeabilization, reduces the cell viability and thus increases the 
possibility that rare clones might be lost, the collected cells were lysed, and the ssTorA-
26-10 scFv genes in that population were recovered by PCR.  The PCR product was 
cloned back to the original vector and electroporated into E. coli XL1-Blue for plasmid 
propagation.  Purified plasmid was obtained from this strain and used to transform E. coli 
FA113 to give rise to 6x104 transformants.   After growth of the pooled transformants in 
liquid TB media supplemented with antibiotic, cells were labeled and subjected to a 
second round of sorting as above.  The cell fluorescence after each round of sorting 





Figure 2.4. Enrichment of fluorescent clones by FACS.  Histograms showing the mean 
fluorescent intensities of the original scFv library and the population of collected cells after each 
round of sorting.  M1, marker indicating the percent of the total population in that region with the 
corresponding geometric mean fluorescence intensity, m. 
 
Clones isolated after transformation from the third round were grown in 96-well 
plate format, and the fluorescence of each clonal population was determined.  One clone 
C8, exhibiting the highest increase in fluorescence relative to the parental 26-10 scFv, 
was analyzed further.  The fluorescence of cells expressing the C8 scFv was dependent 
on an oxidizing cytoplasm and was abolished in a ∆tatC strain background indicating 
that, as with the parental 26-10 scFv, both disulfide bond formation and a functional Tat 
pathway are required for export (see Figure 2.5).  Consistent with the observed 2-fold 
increase in fluorescence observed with whole cells expressing the C8 scFv, about 40% of 
the C8 scFv protein was found in the periplasm compared to 20-25% for the parental 





Figure 2.5. Fluorescence of C8 versus WT 26-10.  Histograms of cells expressing ssTorA-2610C8 





Figure 2.6. Subcellular localization of the C8 scFv.  Western blot of cells expressing ssTorA-C8 
26-10.  Cells were fractionated using the osmotic shock procedure described above.  Amounts 
corresponding to equal number of cells were loaded in each lane as in Figure 3.2 to allow direct 
comparison. 
 
DNA sequencing revealed that the C8 clone contained 7 amino acid substitutions, 
6 in the framework and 1 (L47 Leu→Pro, Kabbat numbering [44]) in CDR L2 (Figure 
2.7).  This residue does not make contact with the hapten.  Also, none of the mutated 
positions corresponds to a second shell residue [45].  Second shell residues have side 
chains that are not directly involved in binding but whose orientation could affect the 
ligand from contacting the binding residues.  In addition to C8, several lower 
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fluorescence clones (about 50% increase in whole cell fluorescence relative to the 
parental 26-10 scFv) were also isolated and were found to contain one or two amino acid 




Figure 2.7. Alignment of C8 and WT scFvs.  The positions of the amino acid substitutions in the 
C8 26-10 are shown.  The residues that comprise the CDRs and linker are also indicated. 
 
2.3.3 Expression and Characterization of the C8 scFv 
To further confirm the increased export of the C8 scFv to the periplasm via the 
Tat pathway, purified protein was needed in order to characterize the mutant scFv.  1 L 
cultures were used to express enough C8 and WT scFvs for capture by immobilized metal 
chromatography and purification by gel filtration FPLC.  The monomeric antibody 
fragments were purified to >95% homogeneity as determined by SDS-PAGE and 
quantified by bicinchoninic acid assay.  The 26-10 and C8 scFvs were produced 
respectively at 0.13 mg/L/OD and 0.24 mg/L/OD.  The increased yield of the purified C8 
scFv is consistent with the approximately 2-fold higher level of periplasmic protein 
observed by Western blot analysis and with the increased cell fluorescence of C8 scFv-
expressing cells (see Figures 2.3, 2.5 and 2.6). 
Using the purified scFv protein, we sought to determine if the mutations in the C8 
scFv affected the hapten binding kinetics or equilibrium dissociation constant.  ELISA 
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assays indicate that the mutant C8 and WT 26-10 scFv have indistinguishable binding 
properties (see Figure 2.8).  To further examine any subtle difference in hapten affinity, 
the hapten binding kinetics were determined quantitatively by surface plasmon resonance 
on a BIACore 3000 instrument.  The association rate constant, ka, dissociation rate 
constant kd and the equilibrium dissociation rate constant KD for C8 were 3.8 x 105 M-1 s-
1, 1.4 x 10-3 s-1 and 3.8 nM respectively and were statistically indistinguishable from the 
respective values for the parental 26-10 scFv (4.8 x 105 M-1 s-1, 1.7 x 10-3 s-1 and 3.5 nM).  
The data above show that, consistent with the screening strategy that led to its isolation, 
the ability of C8 to confer increased cell fluorescence was not due to a higher hapten 




Figure 2.8. ELISA analysis of C8 and WT scFvs.  Equal amounts of purified scFv were used to 
analyze binding to digoxigenin-BSA by ELISA. 
 
Finally, a higher periplasmic yield of C8 was observed only when the protein was 
exported via the Tat pathway.  Replacement of the ssTorA signal peptide with the pelB 
signal peptide directs export through the Sec pathway [25].  Precursor proteins competent 
for Sec export are maintained in a largely unfolded conformation within the cytoplasm in 
 63
contrast to proteins that are exported through Tat [46].  Since the formation of disulfide 
bonds inhibits Sec export, the accumulation of the scFv in the periplasm was examined in 
E. coli DHB4 which has a reducing cytoplasm and is isogenic to the oxidizing strain 
FA113 that had been used for Tat export.  The fluorescence of cells expressing the 
ssPelB-26-10 C8 scFv fusion was indistinguishable from that of cells expressing the 
parental ssPelB-26-10 scFv (see Figure 2.9).  Western blot analysis further revealed 
identical amounts of C8 and WT 26-10 scFvs in periplasmic fractions when exported by 
the Sec pathway (see Figure 2.10).  Thus, the more efficient periplasmic localization of 




Figure 2.9. Sec export of C8 and WT scFvs.  Fluorescence histograms of E. coli DHB4 




Figure 2.10. Western blot of cell fractions.  Cell fractions obtained by cold osmotic shock of E. 
coli DHB4 showing Sec export of the mutant C8 and WT 26-10.  The blot was probed with anti-
GroEL to show that cytoplasmic protein leakage into the periplasmic fraction did not occur. 
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As shown in Figures 2.3 and 2.6, the higher amount of C8 scFv in the periplasm 
was accompanied by a reduction in the amount of protein that remained in the cytoplasm. 
The observed increase in the yield of periplasmic scFv can be due to one or more of the 
following factors:  (i) increased stability of the C8 protein to degradation in the 
periplasm; (ii) more efficient targeting of the precursor polypeptide to the TatABC 
translocon; (iii) greater export competence.  The finding that export of C8 and the 26-10 
scFvs via Sec resulted in equal periplasmic yields suggests that the two proteins have 
similar in vivo stability.  Targeting of the scFvs to the Tat translocon is mediated by the 
signal peptide.  Since the mutations in the C8 scFv are all located in the mature protein 
they are less likely to influence the efficiency of translocon targeting [47].  The higher 
ratio of periplasmic to cytoplasmic C8 compared to the parental 26-10 scFv is consistent 
with the third possibility discussed above, namely more efficient export.   Unfortunately, 
as is the case with many Tat precursor polypeptides, processing by signal peptidase in the 
periplasm is inefficient, and therefore the kinetics of export cannot be measured using 
pulse-chase techniques. 
2.3.4 Folding Characteristics of the C8 scFv 
We reasoned that the higher yield of periplasmic C8 may be related to the export 
competence of the protein in the cytoplasm which in turn is influenced by its folding 
kinetics.  Therefore, in an effort to further elucidate the molecular basis for the improved 
export of C8 relative to the 26-10 scFv, we examined their guanidine HCl (GdnHCl)-
induced equilibrium denaturation, folding kinetics and aggregation propensities.  GdnHCl 
causes proteins to denature because it interferes with the hydrogen bonding network in 
water.  By incubating a protein in different concentrations of GdnHCl, an equilibrium 
amount of folded versus unfolded protein is established.  Fluorescence spectroscopy 
measures the amount of fluorescence from exposed tryptophan residues.  As a higher 
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fraction of the protein molecules are unfolded, more tryptophan residues are available to 
fluoresce, therefore making the fluorescence proportional to the amount of unfolded 
protein. 
The GdnHCl-induced denaturation transition was determined both for oxidized 
and for completely reduced scFv proteins (see Figure 2.11).  Fluorescence spectroscopy 
revealed that increasing concentrations of GdnHCl caused a shift in the fluorescence 
emission maxima from 325 nm to 360 nm for the fully denatured proteins.   Normalized 
transition curves were prepared based on the change in emission intensity at 360 nm.   
For the reduced C8 and 26-10 scFvs, the transition curves were essentially 
superimposable with midpoints at 2.75 M and 2.65 M, respectively.  The transition 
midpoints for the oxidized scFvs exhibited a similar difference (3.60 M for C8 compared 




Figure 2.11. GdnHCl-induced denaturation equilibrium curves.  Data is shown for both the 
reduced (Rd) and oxidized (Ox) mutant C8 and WT scFvs.  The fitted lines are provided as visual 
aids. 
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Since the stability of the two scFvs was essentially identical, we decided to 
determine if their rates of folding were different.  The folding kinetics were determined 
by diluting completely reduced and denatured proteins from 5 M GdnHCl to a final 
concentration of 0.5 M GdnHCl while following the change in fluorescence at 325 nm.  
Consistent with previous studies [36], the folding reaction exhibited three distinct phases.  
The first phase is complete during manual mixing (~10 sec) and accounts for 15-30% of 
the total amplitude of the fluorescence increase.  The second phase follows first order 
kinetics and is completed within 180 seconds.  Finally, a third slow phase was also 
observed.  The third, slow phase has been shown to arise from peptidyl proline 
isomerization and exhibits a macroscopic rate of <10-3 s-1 [24, 48].  Differences in the 
folding kinetics of C8 and 26-10 were observed during the second phase (see Figure 
2.12).  The increase in fluorescence data could be fit to a single exponential equation 
resulting in a rate constant of 0.063 s-1 for C8 and 0.025 s-1 for 26-10.  In other words, the 
second critical phase in the folding of C8 occurs at a rate that is approximately 2.5 times 
higher than that of the parental 26-10 antibody.  It should be noted that cysteine oxidation 
in E. coli trxB gor strains is relatively slow [35], and therefore the formation of the 
disulfide bonds in scFvs occurs at a late step, most likely prior to or concomitant with cis-




Figure 2.12. Renaturation of scFvs.  By following the renaturation of the C8 and WT 26-10 
scFvs, their kinetic rates of refolding were determined from the fitted curves. 
 
Finally, we determined the aggregation propensity of the scFv fragments by 
monitoring the increase in light scattering following prolonged incubation in different 
concentrations of GdnHCl.   Aggregation of protein while it is folding would lower the 
amount of competent protein available for export via the Tat pathway.  As protein 
aggregates form, they scatter more light than soluble protein.  Thus an increase in light 
scattering reflects an increase in aggregation.  An increase in light scattering was 
observed following prolonged incubation in GdnHCl concentrations near the midpoint of 
the denaturation transition of both the reduced and the oxidized proteins (see Figure 
2.13).  In 2.5-3.0 M GdnHCl, the reduced C8 scFv exhibited approximately 30% lower 
light scattering than 26-10; a smaller difference was observed for the oxidized proteins, 





Figure 2.13. Aggregation of scFvs.  Light scattering was used to determine the aggregation of 
both the A) reduced and B) oxidized C8 and WT scFvs upon prolonged incubation in GdnHCl.  
Bars show the light-scattering at the indicated GdnHCl concentrations.  Lines represent the 




Export of the anti-digoxin 26-10 scFv antibody fragments via the Tat pathway by 
means of the ssTorA signal peptide can only occur in E. coli strains having an oxidizing 
cytoplasm that allow the formation of its two disulfide bonds.  However, we found that 
the yield of Tat-exported 26-10 scFv in the periplasm was only 0.13 mg/L/OD which is 
considerably less than the yield obtained when export is mediated by a Sec signal peptide 
(approximately 1 mg/L/OD, unpublished laboratory result).  A large fraction of the 
ssTorA-26-10 scFv is localized in the cytoplasm and is incompetent for export (see 
Figure 2.3).  Accumulation of Tat precursor proteins in the cytoplasm is routinely 
observed not only with heterologous proteins but also with many native Tat substrates 
expressed at non-physiological levels [37-40].  We took advantage of a quantitative assay 
for monitoring the amount of periplasmic 26-10 scFv at the single cell level [28] to 
search for mutations in the mature protein that increase the export yield.  A single clone, 
C8, which exhibited a 2-fold higher yield of periplasmic scFv and a proportional 
reduction in the amount of protein that remained in the cytoplasm, was isolated from a 
library of 6x106 random mutants.  Increased periplasmic accumulation was only observed 
when the protein was exported via the Tat pathway indicating that the mutations in the 
C8 scFv specifically affected a step important in protein translocation.   
Comparison of the folding properties of the mutant and the parental scFvs 
revealed that the former was only marginally more stable to GdnHCl denaturation under 
either reducing or oxidizing conditions.  However, kinetic experiments showed that for 
the reduced C8 scFv, the critical second phase in refolding is accelerated substantially.  In 
addition, the C8 scFv exhibited a reduction in the aggregation of a folding intermediate 
populated at denaturant concentrations near the transition midpoint.  The folding 
properties of the C8 scFv bear many similarities to those of the anti-β-galactosidase 13R4 
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scFv that was isolated earlier based on its ability to fold into an active conformation 
within the reducing environment of the E. coli cytoplasm [36, 49].  Similar to what we 
found for the anti-digoxigenin scFv mutant examined in the present study, the reduced 
13R4 scFv exhibited a 3-fold acceleration in the intermediate refolding phase and a 
somewhat lower propensity to aggregate compared to its parental protein.  Martineau and 
Betton suggested that the increase in the folding rate of the 13R4 scFv helps prevent off-
pathway interactions that lead to aggregation [36].  A reduction in protein aggregation 
can also play a role in Tat export competence [13].  However, the export of scFvs is a 
complex process that also depends on disulfide bond formation, since only the oxidized 
protein can be translocated and ultimately, on the features that are recognized by the 
folding quality control mechanism of the Tat pathway.   
Regardless of the precise mechanism, our data indicate that the rate of folding 
plays an important role in the export competence of scFv antibodies and possibly of other 
proteins.  Along these lines we note that thioredoxin-1, a protein that exhibits very fast 
folding kinetics [9] when fused to ssTorA is exported with very high efficiency even 
when its expression is driven by very strong promoters (Masip and Georgiou, in 
preparation).  In contrast, when thioredoxin is fused to a signal peptide that directs post-
translational export via Sec, it is localized in the periplasm very inefficiently [9, 50].  
Thus, it is tempting to speculate that Tat export hinges on folding properties that are 
diametrically opposite to those required for post-translational export through the Sec 
translocon.  If that is the case, genetic screens for improved Tat export could be useful for 
selecting mutants of soluble proteins exhibiting faster folding.  Apart from its practical 
ramifications for protein expression, the isolation of faster folding proteins can provide 
insights into the nature of the rate limiting steps in folding. 
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Finally, the C8 scFv mutant has an increased yield of approximately two-fold 
over the parental 26-10 scFv.  Therefore, the genetic selection for a mutant scFv with 
improved periplasmic yield through the Tat pathway was successful.  However, since this 
improved yield is still lower than that achieved when export is targeted to the Sec 
pathway, additional studies must be performed to further increase the yield and allow the 
Tat pathway to become a viable mechanism for protein production in biotechnology.  
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Increasing Tat Export Efficiency 
3.1 INTRODUCTION 
As discussed in Chapter 1, the Tat pathway exhibits a quality control feature that 
results in the export of only fully and correctly folded proteins to the periplasm [1].  
However, secretion via Tat is not widely utilized since its efficiency is much lower than 
that of the Sec export pathway [2].  In addition, protein yields obtained through the Tat 
pathway do not approach those obtained from Sec export which, for antibody fragments, 
typically exceed 1 g/L [3, 4] although this is from fermentation studies and may not be 
typical.  As indicated in the last chapter, the yield of the C8 scFv was only 0.24 
mg/L/OD.  This lower yield may be due to the fact that the export machinery can be 
saturated by overexpressed target proteins.  Saturation of the Tat machinery has been 
reported even for native Tat export proteins [5-8].  In some instances, the saturation of 
export can be partially relieved by co-expression of other proteins [6, 9].  However, it 
may also be necessary to optimize growth conditions to increase expression and/or 
engineer a better performing strain. 
Recent studies have indicated that overexpression of TatABC results in improved 
secretion [5, 10].  However, since these are all membrane proteins, expression beyond a 
certain level may adversely affect cell growth and will require determining the optimal 
levels experimentally [11].  TatA is believed to form the protein conducting pore [12, 
13], and therefore overexpression of TatA by itself may allow more pores to form by 
increasing the availability of TatA subunits for oligomerization.  Since the Tat pathway 
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uses the proton motive force (PMF) to export proteins, recent work from our laboratory 
has shown that overexpression of PspA, a phage shock protein associated with the 
maintenance of the PMF, partially relieves the saturation of the Tat pathway [6].  DsbC is 
a disulfide isomerase which functions to help periplasmic proteins form correct disulfide 
bonds.  Thus, for disulfided proteins, overexpression of a cytoplasmic version of DsbC 
might help in correct disulfide bond formation [14] allowing more protein to be 
competent for export.  Finally, TorD has been shown to be a chaperone which protects 
the Tat signal peptide from degradation in the cytoplasm before export [15].  This 
protection may allow more precursor proteins to be targeted to the Tat pathway, and 
overexpression of TorD has been shown to increase Tat export [9]. 
Environmental factors such as temperature, pH, and the availability of nutrients 
play an important role in gene expression of both native and recombinant proteins in E. 
coli [16-20].  In addition, proteins tend to fold incorrectly or become insoluble at 
physiological temperatures and therefore, expression typically is carried out at lower 
temperatures [21, 22].   Since the Tat pathway requires proteins to be soluble and 
correctly folded, the growth temperature at induction could play a role in increasing the 
amount of export through the pathway.  Media and pH must also be optimized to not only 
allow for maximum cell growth but also to ensure expression is maximized, i.e., 
translation is not limited due to a lack of availability of amino acids.  pH also can affect 
the PMF by influencing the potential difference across the bacterial membrane [23]. 
To investigate the effect of growth conditions on Tat export, the C8 ssTorA-26-10 
scFv was used as a reporter.  The C8 scFv can only be translocated into the periplasm 
when the gene fusion is expressed in E. coli strains that have an oxidizing cytoplasm, 
such a FA113.  This strain contains mutations in the trxB and gor genes which allow the 
formation of the two disulfide bonds in scFv that are necessary to stabilize the protein [1, 
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24, 25].  As described in the previous chapter, the trxB and gor genes of E. coli maintain 
the reducing nature of the cytoplasm.  Thioredoxins and glutaredoxins can catalyze the 
formation of disulfide bonds in their oxidized state but are kept in a reduced state by 
thioredoxin reductase, encoded by trxB, and glutathione oxidoreductase, encoded by the 
gor gene.   However, due to the accumulation of these oxidized proteins in the cytoplasm, 
the growth rate of these mutant oxidizing strains is slower compared to the WT parental 
strains [24].  Different strains have been created with additional mutations in the gor and 
trx genes to create an oxidizing cytoplasm while attempting to reduce the amount of 
oxidized protein accumulation.  For example, strains DR602 and DR611 are also lacking 
the trxA and trxC genes encoding for thioredoxin and thioredoxin2, respectively.  
Expressing the C8 scFv in these strains may allow the formation of the disulfide bonds 
while providing better growth characteristics than the FA113 strain used previously.  
In this study, we sought to analyze different methods to increase the efficiency of 
Tat export using the 26-10 and the C8 scFv mutant as protein reporters.  The export yield 
of both proteins can be conveniently measured by FACS by monitoring the cell 
fluorescence following permeabilization of the outer membrane and labeling with 
digoxigenin-BODIPY [26].    An increase in Tat export was observed under certain 
conditions.  Combined with the two-fold higher yield of the C8 scFv, the overall yield of 
the anti-digoxin antibody fragment was increased by about 5-fold relative to the 26-10 
scFv.  The effect of growth media, temperature and pH changes were also investigated 
for their effect on Tat export.  However, no changes in these variables had a positive 
impact.  Finally, five different oxidizing cytoplasm strains were also used to express C8 
26-10.  Although some of these produced fluorescence approaching the FA113 strain 
used previously, the cell densities achieved with the other strains were less than that of 
FA113, translating into an overall lower yield of 26-10. 
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3.2 MATERIALS AND METHODS 
3.2.1 Strains and plasmids 
The bacterial strains and plasmids used in this study are listed in Table 3.1.  E. 
coli XL1-Blue cells were used for plasmid propagation. 
To construct the pPspA plasmid, primers PspA.f and PspA.r were used to amplify 
the pspA gene from p99PspA by PCR.  The PCR fragment and empty pBAD18 plasmid 
were digested by XbaI and SacI and ligated forming the pPspA plasmid. 
Using primers TatA.f and TatA.r and genomic DNA as template, PCR was carried 
out to clone the tatA gene.  The DNA fragment containing the tatA gene was digested by 
XbaI and SacI and ligated into similarly digested empty pBAD18 to yield pTatA. 
pTorD pBAD33 was constructed by PCR with primers TorD.f and TorD.r and 
p99TorD pTrc99A as template.  This cloned fragment and empty pBAD33 were digested 
with XbaI and SacI, and upon ligation, pTorD was created. 
The C8 scFv gene in pTorA-2610C8, was used as template for PCR amplification 
with primers C8trc.f and C8trc.r.  The resulting PCR product was digested with NheI and 
XhoI and ligated at the respective sites of pTrc99A.  Ligation resulted in the creation of 
plasmid p99TorA-2610C8.  The p99TorA-2610C8 plasmid was created to ensure plasmid 








Table 3.1. Strains, plasmids, and primers used in this study 
E. coli Strain 
or Plasmid Relevant Genotype or Features Source 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' proAB laclq Z∆M15 Tn10 (Tetr)] Lab collection 
DHB4 MC4100 phoR ∆(phoA ) PvuII ∆(malF)3 F' [lacIqZYA -pro] Lab collection 
FA113 DHB4 trxB gor552 Tn10tetr ahpC* J. Beckwith 
FA113 ∆tatC DHB4 trxB gor552 Tn10tetr ahpC* tatC::spec Lab collection 
DR600 DHB3 ∆trxB (araC Para-trxB) gor::km katG::Tn10tetr ahpC(P166L) J. Beckwith 
DR602 DHB3 ∆trxA ∆trxC trxB::km gor522 Tn10tetr ahpC(T104P) J. Beckwith 
DR611 DHB3 ∆trxA ∆trxC trxB::km gor522 Tn10tetr ahpC( T104P/G141C) J. Beckwith 
SMG96 DHB4 ∆trxB ∆gor ahpC* J. Beckwith 
MJF256.10 DHB4 ∆gshA::km ∆trxB::cm ahpC(V164G) J. Beckwith 
   
pBAD18 araBAD promoter, pBR322 ori, cmr Ref. [27] 
pBAD33 araBAD promoter, pBR322 ori, cmr Ref. [27] 
pTrc99A trc promoter, ColE1 ori, cmr Amersham 
Biosciences 
p99PspA PspA in pTrc99A Lab collection 
pPspA PspA in pBAD18 This study 
pEXT-ABC tac promoter, lacIq, tatA, tatB, tatC, Kanr Ref. [28] 
p∆ssDsbC ∆ssDsbC in pBAD33 Lab collection 
pTatA TatA in pBAD18 This study 
p99TorD TorD in pTrc99A Lab collection 
pTorD TorD in pBAD33 This study 
p99TorA-
2610 
ssTorA-26-10 in pTrc99A Lab collection 
p99TorA-
2610C8 
ssTorA-26-10 mutant C8 in pTrc99A This study 
pTorA-2610C8 ssTorA-26-10 mutant C8 in pBAD18 Chapter 3 
Primers     
PspA.f GCGATGGAGCTCTTAAAGAGGAGAAAAGGTCATGGGTATTTTTTCTCGCT 
PspA.r GCGATGTCTAGAGCATTATTGATTGTCTTGCTTCAT  
TatA.f GCGATGGAGCTCTTAAAGAGGAGAAAAGGTCATGGGTGGTATCAGTATTTG 
TatA.r GCGATGTCTAGAGCATTACACCTGCTCTTTATCG  
TorD.f GCATGAGCTCTTAAAGAGGAGAAAGGTCGGTACCATGACCACGCTGACAG 
TorD.r GCATTCTAGATTATCTGTTTTGGTGGTCG  
C8trc.f GCGGCGACTGACGCTGCTAGCGAAGTT  




3.2.3 Growth conditions, expression and flow cytometry 
Unless otherwise noted, cells were grown at 37oC on LB media with 25 µg/ml 
chloramphenicol and/or 100 µg/ml ampicillian and/or 25 µg/ml kanamycin, as 
appropriate. 
For flow cytometric analysis, cells containing the appropriate plasmids were 
grown overnight in TB media, unless noted otherwise, with the appropriate antibiotics.  
250 µl of overnight culture was used to inoculate 10 ml of fresh media, and after 
incubation with shaking for 1 hour at 37oC, protein expression was induced by the 
addition of arabinose and/or IPTG to a final concentration of 0.2% and 0.1 mM, 
respectively.  The culture was then grown at 30oC, unless noted otherwise, for four hours.  
100 µl of the culture was harvested and labeled as described in Chapter 2.  Depending 
upon the cell density, 3 to 10 µl of each labeled sample was added to 1 ml of 5xPBS in a 
sieve tube before being analyzed on a Becton-Dickinson FACSort flow cytometer with 




3.3.1 Effect of co-expression of various genes on the periplasmic yield of the 26-10 
scFv 
3.3.1.A.  PspA 
PspA is a protein that is equally distributed between the inner membrane fraction 
and cytoplasm [29].  Earlier studies have indicated that PspA helps the cell manage 
membrane-related stress, such as osmotic shock or the blockage of the Sec pore, by 
assisting in the maintenance of the proton motive force (PMF) [8, 30, 31].  Kleerebezem 
et al. have shown that transport of proteins through the Sec pathway is less efficient in 
the absence of PspA while its expression increases the efficiency of Sec export [32].  The 
Tat pathway uses the PMF to drive the translocation of proteins across the membrane and 
recent studies by the Georgiou laboratory have shown that overexpression of PspA 
partially relieves the saturation of the Tat pathway observed during the export of a 
ssTorA-GFP fusion [6].  Therefore, we sought to determine the effect of co-expression of 
PspA on the periplasmic yield of the 26-10 scFv exported via the ssTorA signal peptide. 
The pspA gene was cloned into pBAD18 to allow arabinose inducible, high level 
expression and compatibility with the p99TorA-2610 and p99TorA-2610C8 plasmids.  
pTrc99A was used for the 26-10 and C8 scFvs since it allows a high level of inducible 
expression with IPTG.  The pPspA plasmid was used to transform E. coli FA113 cells 
containing either of the p99TorA-2610 and p99TorA-2610C8 plasmids that encode, 
respectively, the 26-10 and the C8 scFvs.  Following growth and induction of PspA and 
scFv protein synthesis with arabinose and IPTG, the periplasmic yield of scFv was 
analyzed by flow cytometry.  As seen in Figures 3.1B and 3.2B, the fluorescence signals 
from the expression of the 26-10 and the C8 scFvs were increased 1.9-fold and 1.5-fold, 
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respectively.  An equivalent fold increase was observed for each scFv when the 
experiment was duplicated. 
3.3.1.B.  ∆ssDsbC 
DsbC is an isomerase that catalyzes the rearrangement of incorrectly formed 
disulfide bonds and is present in the periplasm of bacteria [33].  DsbC has also been 
found to have chaperone activity as well in that it assists in the folding of proteins that do 
not contain disulfide bonds [34].  Overexpression of DsbC has been shown to increase 
the isomerization and yield of non-native disulfide-containing proteins such as human 
nerve growth factor [35], tissue plasminogen activator [36] and scFvs [37]. 
By removing the putative signal peptide from DsbC, the enzyme is confined to the 
cytoplasm where it can catalyze correct disulfide bond formation in trxB gor mutant 
strains having an oxidizing cytoplasm.  By facilitating disulfide bond formation in the 
cytoplasm, DsbC can increase the amount of protein that is competent for export [14].  
Since the cytoplasm is oxidizing in the FA113 strain, it would allow DsbC to function as 
if it were normally in the periplasm.  
The p∆ssDsbC plasmid was used to transform FA113 cells expressing the 26-10 
and C8 scFv fusions as above.  Cell growth and induction were carried out as for cells co-
expressing PspA (see above).  As seen in Figures 3.1C and 3.2C, the fluorescence signals 
of the 26-10 and C8 scFvs were increased 1.6-fold and 1.4-fold, respectively.  The 
increase in fluorescence of the cells expressing the C8 scFv is slightly lower than that of 
the 26-10 scFv.  DsbC is normally regenerated to its active state by transfer of electrons 
from the periplasmic side of DsbD, located in the inner membrane.  Since this 
regeneration mechanism is not available to cytoplasmic DsbC, recycling of the enzyme to 
its reduced state must be mediated by other mechanisms and may be the rate limiting step 
in disulfide bond formation.   
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3.3.1.C.  TorD 
TorD is a chaperone which protects the ssTorA signal peptide in the native 
ssTorA-TorA Tat substrate from degradation in the cytoplasm before export  [15].  In 
addition, TorD also interacts with the TorA protein to promote its stability at higher 
growth temperatures [38].  By binding to immature proteins, TorD has been shown to 
prevent the premature binding of precursor proteins to the Tat machinery before proper 
cofactor insertion [39].  Recently, Li et al. found that the expression of TorD increases 
the export of ssTorA-GFP three-fold [9]. 
We examined whether co-expression of TorD can also facilitate the export of a 
protein with a more complex folding pattern, such as a scFv antibody.  The pTorD 
plasmid was constructed by amplifying torD by PCR from p99TorD and ligating the 
digested DNA fragment into the XbaI and SacI sites of pBAD33.  pTorD was 
transformed into FA113 cells containing the scFv fusions.  Flow cytometry revealed that 
co-expression of TorD had a slight effect on cell fluorescence and resulted in a 40% and 
30% increase for the 26-10 and C8 scFvs, respectively (see Figures 3.1D and 3.2D).  This 
small increase for both scFvs may be due to the protection of the ssTorA peptide by TorD 
while awaiting export.  However, the increase in export of the scFvs was lower than the 
three-fold increase reported earlier for the ssTorA-GFP protein reporter.  This may be 
attributed to differences in folding between the scFv and GFP, in that the scFv folding or 
disulfide formation may sterically interfere with the binding of TorD.  Perhaps, the lower 
amount of protection to the ssTorA signal peptide conferred by TorD results in 
proteolysis of the signal peptide at some stages of the folding pathway.   
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3.3.1.D.  TatA 
As discussed in Chapter 1, TatA is expressed by cells at approximately 20 times 
the level of the other two essential Tat pore component proteins, TatB and TatC [40], 
indicating that TatA most likely forms the majority of the Tat pore [13, 41, 42].  Electron 
microscopy of a Tat complex revealed the formation of pore-like structures comprised 
mainly of TatA.  These pore-like structures appeared to be occluded on the cytoplasmic 
side of the inner membrane consistent with the proposed role of TatA as the main 
component of the gated Tat pore [12].  Overexpression of TatA may allow more pores to 
form by increasing the TatA subunits available for oligomerization and, in turn, increase 
the flux of protein exported across the membrane.  The tatA gene was cloned into 
pBAD18 to allow a high level of expression.  Following transformation of pTatA into the 
FA113 cells containing the two anti-digoxin scFvs, export was evaluated by flow 
cytometry as above.  Once again, only a slight increase in cell fluorescence was observed 
(see Figures 3.1E and 3.2E).  Flow cytometric analysis of duplicate cultures for the 26-10 
and C8 scFvs produced statistically similar increases in fluorescence, respectively. 
3.3.1.E.  Co-expression of the TatABC operon 
Thus, recent studies have indicated that overexpression of TatABC can improve 
secretion through the Tat pathway [5, 10, 43].  However, since these are all membrane 
proteins, overexpression may adversely affect cell growth [11], reducing the overall 
protein yield even though export is increased. 
The TatABC proteins were expressed as an operon under the control of the tac 
promoter from the pEXT-ABC plasmid [28].  Upon induction of protein synthesis, the 
expression of TatA, TatB, and TatC increases 10-fold relative to the basal level observed 
in cells where TatABC synthesis is directed from its native promoter in the chromosome 
[28].  Cell growth and protein synthesis was carried out as above except that IPTG was 
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used to induce both TatABC and scFv synthesis. Figures 3.1F and 3.2F show the 
fluorescence histograms of cells co-expressing the Tat pore proteins.  In this case, a 
significant increase of 2.1- and 2.4-fold, respectively, in the fluorescence of the cells 
expressing the 26-10 and C8 scFvs, was observed by flow cytometry.  Overexpression of 
TatABC in both cases show that the number of Tat translocases limited the efficiency of 




Figure 3.1. Effect of co-expression of various proteins on the export of 26-10 as monitored by 
flow cytometry.  E. coli strains DHB4, FA113 and FA113 ∆tatC were transformed with p99TorA-
2610 together with plasmids expressing the appropriate protein factor.  A) Expression of the 
ssTorA-26-10 control.  ssTorA-26-10 co-expressed with B) PspA, C) ∆ssDsbC, D) TorD, E) 





Figure 3.2. Effect of co-expression of various proteins on the export of C8 scFv as monitored by 
flow cytometry.  E. coli strains DHB4, FA113 and FA113 ∆tatC were transformed with p99TorA-
2610C8 together with plasmids expressing the appropriate protein factor.  A) Expression of the 
ssTorA-26-10 mutant C8 control.  ssTorA-26-10 mutant C8 co-expressed with B) PspA, C) 






3.3.2 Effect of growth conditions on Tat export of scFv antibodies 
Environmental factors such as temperature, pH and nutrient composition play an 
important role in determining the growth rate and in protein expression.  These factors 
not only influence the maximum cell density a culture can obtain, but can also limit 
recombinant protein expression by preferentially increasing native gene and protein 
expression over recombinant proteins or not supplying enough amino acids in the media 
for high levels of translation [19, 20].  A higher growth temperature allows for a faster 
growth rate.  On the other hand, proteins tend to fold incorrectly or become insoluble at 
supra-optimal or even physiological temperatures so induction of expression typically is 
carried out at lower temperatures [21, 22].  This is especially significant for Tat export 
since the Tat pathway requires proteins to be soluble and correctly folded in order to be 
competent for export.  A high induction temperature could play a role in protein 
misfolding or aggregation, decreasing the amount of export through the pathway.  In 
addition, growth at lower temperatures increases the permeability of the outer membrane 
[44] and is preferred for flow cytometric analysis because it allows better penetration of 
the fluorescent probe.   
We sought to examine the effects of the growth and induction temperatures on the 
fluorescence of cells expressing the C8 scFv antibody exported via the ssTorA signal 
peptide.  The C8 scFv was used as a reporter protein because it confers higher cell 
fluorescence and therefore the signal-to-noise ratio in these experiments is maximized 
relative to the export of the 26-10 scFv.  Different growth media may allow achievement 
of higher cell densities, the cell to maintain the oxidizing cytoplasm more efficiently or 
increase the efficiency of transcription, translation or folding of the C8 scFv.  The effect 






Figure 3.3. Media and temperature effects on cell fluorescence.  E. coli FA113 cells containing 
the mutant C8 ssTorA-26-10 construct were grown at 37oC for one hour, protein synthesis was 
induced by arabinose and the cells were transferred to a different temperature as indicated and 
incubated for an additional four hours.  The fluorescence histogram for this control condition, i.e. 
the conditions used in other studies reported in this thesis, is shown in the box.  Each column 
represents a different four hour induction temperature used after growth at 37oC for one hour.  
Each row represents the media used for those cultures.  Each culture was run in triplicate, and the 
histograms provided are representative of each triplicate set of samples.  m, geometric mean 
fluorescence intensity of the histogram. 
 
The flow cytometric results are shown in Figure 3.3.  Not only were the highest 
cell densities achieved in TB media, but also the highest fluorescence was observed under 
the conditions used previously in this thesis.  TB media is the most nutrient rich media 
tested, thus allowing the cells to reach higher densities.  Using TB media as the starting 
point, we proposed that the switch from growth at 37oC to induction at 30oC might cause 
a stress response in the cells.  Therefore, cultures were kept at a constant temperature for 
both their growth and induction phases.  Adjusting the media pH was also examined 
since the growth pH can affect the PMF that is maintained by the cell by altering the 
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concentration differences of the ions on each side of the inner cell membrane.  Since Tat 
export relies on the PMF for the energy necessary for translocation, a cell that can 
establish a higher PMF may have increased export. 
As shown in Figure 3.4, growth at 37oC in TB media at pH 7.2 followed by 
protein synthesis at 30oC produced the highest fluorescence.  Growth and induction at a 
lower temperature resulted in a lower level of fluorescence that was observable in the 
triplicate samples for each conditions.  Growth at a more basic or acidic pH also caused a 
decrease in the fluorescence of the cells.  A molecular basis for the effect of pH on export 





Figure 3.4. Temperature and pH effects on cell fluorescence.  E. coli FA113 cells transformed 
with pTorA-2610C8 were grown in TB media at the conditions indicated.  Following growth at the 
indicated temperature, protein synthesis was induced with arabinose, and the cells were incubated 
at the indicated temperature for an additional four hours.  The fluorescence histogram for the 
optimal growth conditions is shown in the box.  Each column represents a different one-hour 
growth and four hour induction temperature.  Each fluorescence histogram is a representative 
sample from a set of triplicate cultures.  m, geometric mean fluorescence intensity of the 
histogram. 
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3.3.3 Fluorescence in various oxidizing strains 
Since scFv proteins have two intramolecular disulfide bonds, an E. coli strain that 
has an oxidizing cytoplasm is used to allow oxidative protein to form [1, 24, 25].  As 
discussed in Chapter 2, strains with an oxidizing cytoplasm are necessary in order for the 
scFv protein to be competent for export through the Tat pathway.  In E. coli, the trx and 
gor genes play a key role in maintaining the reducing nature of the cytoplasm [45].  
Thioredoxin reductase reduces thioredoxins which in turn reduce disulfide bonds [46, 
47].  Similarly, glutathione is reduced by the glutathione reductase enzyme encoded by 
the gor gene [48].   
However, maintaining an oxidizing cytoplasm adversely affects the growth rate 
and cell viability of the FA113 strain since native proteins that are normally reduced are 
now partially oxidized, affecting their function.  Recently the Beckwith laboratory 
created a set of strains having different mutations that result in an oxidizing cytoplasm.  
Different gor and trx genes have deletions in the genes encoding different components of 
the thioredoxin or glutathione reduction pathways.  Specifically, strain MJF256.10 is 
lacking the gshA gene that codes for gamma-glutamate-cysteine ligase, the enzyme 
involved in glutathione synthesis [24].  Without glutathione, glutathione reductase has no 
substrate to reduce thereby inactivating the glutathione reduction pathway.  The trxB and 
gor genes have been deleted from the chromosome in strain SMG96 rather than having 
mutations in them as in FA113.  Strain DR600 is similar except on the trxB gene had 
been deleted from the chromosome.  Strains DR602 and DR611 are deficient in the trxA 
and trxC genes along with trxB and gor genes present in the FA113 strain.  These two 
additional genes encode for thioredoxin and thioredoxin2, respectively, and their deletion 
prevents the accumulation of oxidized thioredoxins in the cytoplasm. 
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The pTorA-2610C8 plasmid was used to transform E. coli strains DR600, DR602, 
DR611, MJF256.10 and SMG96.  Transformants were grown in TB media and induced 
as above and flow cytometry was used to analyze cell fluorescence.  As seen in Figure 
3.5, E. coli FA113 had the highest fluorescence intensity followed closely by strains 
DR611, DR602 and DR600.  The optical densities of the cell cultures of the tested strains 
were all less than those attained by E. coli FA113.  E. coli FA113 achieved a final optical 
density of 4.1 at 600 nm while E. coli strains DR600, DR602, DR611, SMG96 and 
MJF256.10 achieved densities of 2.2, 0.3, 0.4, 1.5 and 2.2 at 600 nm, respectively.  
Therefore, although their fluorescent intensities were similar to that of FA113, their lower 
optical densities of the liquid cell cultures translates to a significantly lower overall yield 




Figure 3.5. Cell fluorescence in different E. coli strains containing mutations that render the 
cytoplasm oxidizing.  Plasmid pTorA-2610C8 that encodes the mutant C8 scFv was used to 
transform various E. coli oxidizing cytoplasm strains.  E. coli FA113 which was used in the other 






In this study, we sought to explore methods to increase the efficiency of export 
through the Tat pathway to render it a more useful means of protein production.  The low 
yields of exported protein have hampered the use of Tat in biotechnology even though it 
offers a quality control advantage in that it exports only fully and correctly folded 
proteins to the periplasm.  Using the 26-10 and C8 scFvs as reporters, we first evaluated 
the effect of co-expression of several proteins known or suspected to affect Tat export.  
Cell fluorescence, due to the binding of a fluorescent hapten by the scFv antibodies in the 
periplasm, was used to assay the amount of Tat secreted protein.  The largest increase in 
protein export was observed by co-expressing the three proteins that comprise the Tat 
translocon, namely TatA, TatB and TatC.  A 2.4-fold increase in fluorescence was 
observed indicating that the rate limiting step in export may be the number of Tat pores 
available for protein export.  By providing more translocon complexes, more competent 
scFv protein molecules can interact with the complex and be exported.  In addition, we 
also investigated the effect of temperature, pH and growth media on the growth and 
fluorescence intensity of cells expressing the C8 ssTorA-26-10 scFv.  However, we found 
that growth in TB media of cells incubated at 37oC and then shifted to 30oC for induction 
of protein synthesis was optimal for both achieving the highest cell density and maximum 
fluorescence, and hence, protein export per cell.  Although lower induction temperatures 
could allow the scFv to be more soluble, we found that the fluorescence intensity 
decreased.  This could indicate that the lower temperatures may slow the rate of 
expression and negate any beneficial effects gained by increased solubility. 
Finally, we considered the use of alternate strains of E. coli which contained 
mutations in different gor and trx genes encoding different components of the thioredoxin 
or glutathione reduction pathways which normally maintain the native, reducing 
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cytoplasm.  Essential proteins and enzymes may be oxidized when these pathways are 
inactivated leading to a reduction in cell growth and viability.  These strains were 
recently created to supply the oxidizing cytoplasm necessary for disulfide bond formation 
while attempting to reduce the negative side effects of the oxidizing cytoplasm.  These 
strains were transformed with the pTorA-2610C8 plasmid, grown and induced as 
described above, and analyzed by  flow cytometry.   Although their cell fluorescent 
intensities were similar to that of strain FA113, their liquid cell cultures achieved lower 
optical densities which translates to a significantly lower overall yield of scFv protein. 
As a benchmark, a 30-fold increase in fluorescence is seen over background 
fluorescence when 26-10 is exported via the Sec pathway [26].  The current maximum 
fluorescence achieved in this study was 16-fold over background.  Hence, other methods 
of improvement need to be investigated in order to increase the level of Tat export to that 
of the Sec pathway.  One of these methods may be to engineer a better strain based on the 
E. coli FA113 strain.  For example, an additional TatABC operon under the control of an 
inducible promoter could be placed on the chromosome.  Therefore, an additional protein 
like TorD could be co-expressed with the C8 ssTorA-26-10 fusion while TatABC is 
overexpressed from the new operon.  This approach could yield increased fluorescence 
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FACS Screening for the Selection of Mutant Proteins Resistant to 
Degradation by the AAA+ Protease ClpXP 
 
4.1 INTRODUCTION 
As described in the first chapter, proteolysis is used to regulate response to 
environmental factors and for the disposal of proteins that have become unfolded and/or 
chemically damaged [1-4].  ATP-dependent proteases are present in most cells and 
subcellular compartments such as the eukaryotic proteasome, Clp proteases in bacteria, 
Lon proteases in mitochondria and bacteria and membrane-bound proteases in 
mitochondria (Yta10/12 and Yme1), chloroplasts (FtsH) and bacteria (FtsH or HflB) [5].  
The Clp proteases in bacteria ClpAP, ClpXP and ClpYQ are responsible for proteolysis 
of sigma factors that play a role in regulating gene expression [6] and degradation of 
damaged proteins and proteins from ribosomes that have stalled during translation [7].  
The serine-type protease ClpP of E. coli is the best studied of these prokaryotic proteases.  
It is composed of two seven-subunit rings comprised of 14 identical subunits with an 
internal cavity only accessible through narrow axial channels [8].  Since this channel is 
only accessible to small peptides, the proteolytic capability of ClpP is limited [9]. 
ClpP associates with the ATP-dependent chaperones, ClpA or ClpX.  The ClpAP 
or ClpXP complex can degrade folded proteins.  ClpA and ClpX are composed of six 
subunits arranged in a hexagonal ring that can associate with either or both sides of ClpP, 
but recognize different degradation tags [10, 11]. Both have the role of binding the target 
protein by recognizing a degradation tag, unfolding the protein, and translocating the 
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protein into the proteolytic chamber of ClpP [12, 13].  Studies by Lee et. al. [5] used 
mutant proteins in which the C-terminus was connected to the polypeptide chain by a 
linker at various points to create a circular protein.  Degradation tags were then attached 
to the N-terminus and also the C-terminus for all of the mutants.  Degradation of the 
circular proteins did not depend on the global stability of the protein, as determined by 
the free energy of unfolding, but rather by the local structure next to the degradation tag.  
The conclusion of this research was that the Clp system degrades proteins by 
progressively unraveling them from their degradation signal.  Also, Burton et al. [14] 
determined that, even for a wide range of protein stabilities, the ClpXP protease degraded 
each mutant at a rate that varied by less than a factor of two.  This indicated that proteins 
are unfolded by the application of a mechanical force to the degradation tag causing the 
unfolding of the protein structure neighboring the tag [14, 15]. 
We hypothesized that since the ClpA and ClpX chaperones unravel proteins by 
applying a mechanical force to unfold them, the ClpXP system could be utilized as a 
method to isolate proteins that are more resistant to shear.  In other words, proteins that 
are more resistant to degradation by the ClpXP system are therefore more resistant to the 
shear force used to unfold the protein.  Proteins that can withstand higher shear forces 
before they unfold can be useful in applications where anchored proteins are subjected to 
blood flow [16] and cell adhesion by receptor-ligand interactions that are also subjected 
to shear forces in blood flow [17].  For example, research is being conducted into 
methods to increase the adhesion of endothelial cells to surfaces by changing the binding 
properties of intergrins, a class of cell adhesion molecules that bind to ligands containing 
the arginine-glycine-aspartic acid (RGD) peptide sequence [18].  In addition, these 
intergrins are also used to bind different proteins involved in wound healing [19].  In both 
cases, the cells or proteins are subject to physiologically relevant shear forces induced by 
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blood flow.  An improved protein that does not unfold under these conditions so that it 
maintains its function can lead to better attachment of cells to biomedical implants or 
improved wound-healing treatments.  Researchers are currently mutating single amino 
acids near the RGD binding site in order to increase the binding of these ligands.  
However, mutations in the framework regions surrounding the binding sites may also 
increase binding affinities by stabilizing the protein’s conformation and therefore the 
binding site, as is the case with antibodies [20, 21].  Therefore, a screen that isolates 
mutants more resistant to mechanical unfolding would be beneficial in order to obtain 
proteins that can bind ligands under the shear conditions associated with blood flow. 
In addition to engineering more stable proteins, being able to control the Clp 
system in E. coli may allow greater yields of protein since cytoplasmic proteolysis would 
be reduced [22].  For example, recombinant proteins that are overexpressed in E. coli 
may aggregate and induce degradation by the Clp system.  Inhibiting the Clp system at 
the start of protein induction would ensure that recombinant protein yields would not be 
decreased by degradation.  Similarly, eukaryotic cells also contain proteases such as the 
proteasome that degrades abnormal polypeptides [23].  Therefore, study of the Clp 
system and its control may lead to a similar control of the proteasome which then could 
be applied to increasing protein production in eukaryotic cells. 
In this study, we employed a genetic strategy that capitalizes on FACS screening 
and was aimed at: (i) identifying genes that, upon multicopy expression, could inhibit 
degradation by the Clp machinery and (ii) isolating intragenic mutations that conferred 
higher resistance of a model protein to degradation by the Clp machinery.  For the first 
study, a genomic library was constructed and screened using a fluorescent reporter 
system discussed below.  Several clones exhibiting higher fluorescence were isolated, 
however, further experiments did not yield any regulators or inhibitors of the Clp system. 
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In addition, several libraries of GFP were constructed and targeted to the Clp 
system using different degradation signals.  It was proposed that different mutations may 
increase the stability of GFP to degradation by Clp thus conferring higher cell 
fluorescence.  Since mechanical stability is an important parameter in the degradation of 
proteins by the Clp machinery, mutants exhibiting higher resistance to Clp would be 
likely to have improved mechanical properties.  This could, in turn, provide a system for 
engineering proteins that are more resistant to shear force.  However, after several 
attempts, no mutant of GFP was isolated that showed any increase in fluorescence when 
used in the same reporter system.  This indicated that no mutations could stabilize GFP, 




4.2 MATERIALS AND METHODS 
4.2.1 Strains and plasmids 
The bacterial strains and plasmids used in this study are listed in Table 4.1.  E. 
coli XL1-Blue cells were used for plasmid propagation. 
To construct the pSsrA-GFP pBAD33 plasmid, primers SsrA.f and SsrA.r were 
used to amplify the SsrA tag from pGFP-SsrA by PCR.  The PCR fragment and pGFP-
SsrA were digested by KpnI and SalI and ligated forming a pBAD33 ssrA-ssrA construct.  
This new construct was digested with SalI and SphI to remove the second ssrA tag.  PCR 
was performed with primers GFP.f and GFP.r and pGFP-SsrA as template to yield 
fragments of full length gfp that were digested with SalI and SphI and ligated into the 
already cut ssrA-ssrA plasmid to create pSsrA-GFP. 
Using primers Xho.f, Xho.r, Sapa48.f, and Sapa49.r and pGFP-SsrA as template, 
overlap PCR was carried out to introduce an XhoI restriction site at position 557 of 714 of 
gfp by changing the WT sequence from CTCCAA to CTCGAG.  The fragment containing 
the full length gfp with the XhoI restriction site was digested by KpnI and SalI and ligated 
into similarly digested pGFP-SsrA to yield pGFPxho-SsrA. 
pGFP-RepA was constructed by PCR with primers Xho.f and RepA.r and 
pGFPxho-SsrA as template to yield a fragment containing the end of gfp with a RepA tag.  
This fragment and pGFPxho-SsrA were digested with XhoI and SphI, and upon ligation, 






Table 4.1. Strains, plasmids, and primers used in this study 
E. coli Strain 
or Plasmid Relevant Genotype or Features Source 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' proAB laclq Z∆M15 Tn10 (Tetr)] Lab collection 
pBAD33 araBAD promoter, pBR322 ori, cmr Ref. [24] 
pTrc99A trc promoter, ColE1 ori, cmr Amersham 
Biosciences 
pGFP-SsrA GFP-SsrA in pBAD33 Lab collection 
pSsrA-GFP SsrA-GFP in pBAD33 This study 
pGFPxho-SsrA GFP-SsrA in pBAD33.  GFP has engineered internal XhoI restriction site. This study 
pGFP-RepA GFP-RepA in pBAD33 This study 
pEno Eno in pTrc99A This study 
pPyrG PyrG in pTrc99A This study 
pPspA PspA in pTrc99A Lab collection 
pPspB PspB in pTrc99A This study 
pPckA PckA in pTrc99A This study 
pSgcX SgcX in pTrc99A This study 
Primers     
Eno.f CCAGCCATGGATGTCCAAAATCGTAAAAATCATC  
Eno.r CCAGAAGCTTTTATGCCTGGCCTTTGAT  
PyrG.f CCAGCCATGGATGACAACGAACTATATTTTTGTG  
PyrG.r CCAGAAGCTTTTACTTCGCCTGACG  
PspB.f CCAGCCATGGATGAGCGCGCTATTT  
PspB.r CCAGAAGCTTTTAGCGATCCCTCCA  
PckA.f CCAGCCATGGATGCGCGTTAACAATGGT  
PckA.r CCAGAAGCTTTTACAGTTTCGGACCAGC  
SgcX.f CCAGCCATGGGTGATTGTTTTACGGTCTACG  
SgcX.r CCAGAAGCTTTCATAATGGATGTGCCTCTTG  
Sapa48.f AGAGGAGAAAGGTACCCATG  
Sapa49.r CGTCGTTTGCTGCGTCGAC  
Sapa50.r CGTCGTTTGCTGCGTCGACTTTGTA  
SsrA.f CTTTGGTACCATGGCAGCAAACGACGAAAAC  
SsrA.r GACGGTCGACAGCTGCTAAAGCGTAGTT  
GFP.f ATGTTTGTCGACAGTAAAGGAGAAGAACTTTTCACT  
GFP.r TTCGAAGCATGCTTATTTGTATAGTTCATCCATGCCAT  
Xho.f CAAAATACTCGAGTTGGCGATGG  
Xho.r CATCGCCAACTCGAGTATTTTGTT  
RepA.r TTCGAAGCATGCTTATTCAATGTCTGCGTAAAGAATATCGGAGATAAATGAT
TGATTCATGTCGACTTTGTATAGTTCATCCAT 
Constructs pEno, pPyrG, pPspB, pPckA, and pSgcX were made by cloning each 
gene from XL1-Blue genomic DNA using each gene’s forward and reverse primer as 
listed in Table 4.1.  Empty pTrc99A plasmid and each cloned gene was digested by NcoI 
and HindIII and ligated to create each new plasmid. 
 104
4.2.2 Library Construction 
A genomic library was constructed from DNA isolated from XL1-Blue cells using 
a Qiagen DNAeasy Kit.  The DNA was digested with Sau3I for 30 minutes which was 
determined to yield fragments approximately 1,000 bases in length.  Empty pTrc99A 
plasmid was digested with BamHI and then treated with calf intestinal alkaline 
phosphatase (CIAP) to prevent self-ligation of the plasmid.  The genomic DNA 
fragments were ligated into the pTrc99A backbone, and the completed ligation mixture 
was electroporated into XL1-Blue cells already containing pGFP-SsrA.  1x106 
transformants were obtained. 
Mutant gfp-ssrA library I was constructed using error-prone PCR [25] with 
primers Sapa48.f and Sapa49.r and pGFP-SsrA as template.  After digestion with KpnI 
and SalI, the resulting DNA fragments and pGFP-SsrA were ligated and electroporated in 
XL1-Blue.  Five clones were sequenced and averaged six mutations per gene for an error 
rate of 0.7%.  The resulting library size was 2x106 transformants. 
Mutant gfp-ssrA library II was constructed in the same manner except that 
Sapa50.r was used to replace Sapa49.r to prevent the mutation of either of the last two 
codons to become stop codons.  Nine clones were sequenced from the resulting 5.1x106 
library, averaging 2 mutations per gfp gene or a 0.3% error rate.  
The final two gfp-ssrA libraries, libraries III and IV,  were constructed using 
error-prone PCR [25] with Sapa48.f and Xho.r primers with pGFPxho-SsrA as template.  
This allowed only mutations to occur in the first 557 of 714 nucleotides of gfp.  The PCR 
products and pGFPxho-SsrA were digested with KpnI and XhoI, ligated, and 
electroporated into XL1-Blue.  Ten clones were sequenced from the resulting 2x107 
library III for an average of 8 changes per gfp or an error rate of 1.4%.  The size of library 
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IV was 5x106 transformants and was created with a lower error rate of 0.3% or 1.7 
mutations per gene as determined from the sequencing of nine clones selected at random. 
4.2.3 Growth conditions, expression and flow cytometry 
Unless otherwise noted, cells were grown at 37oC on LB media with 25 µg/ml 
chloramphenicol and/or 100 µg/ml ampicillin, as appropriate. 
For sorting of the genomic library, 100 ml of LB media containing 25 µg/ml 
chloramphenicol and 100 µg/ml ampicillian was inoculated with 1 ml of library frozen 
stock.  After growth with shaking for 1 hour at 37oC, protein expression was induced by 
the addition of arabinose and isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final 
concentration of 0.2% and 0.1 mM, respectively.  Following a 5 hour induction period, 1 
ml of culture was collected, pelleted at 2,000 g for 5 minutes, and resuspended in 1 ml of 
1x phosphate buffered saline (PBS) before sorting.  Sorting of the mutant GFP libraries I-
IV was carried out in the same manner except only chloramphenicol was used in the LB 
media and arabinose as the inducer.  Sorting was carried out on a Becton-Dickinson 
FACSort flow cytometer with settings as described in Chapter 2 with the exception that 
distilled water was run as sheath for all scans.   
Western blotting was performed as previously described [26] with slight changes.  
After induction, 1 ml of cells were pelleted at 2,000 g for 5 minutes, washed in 1xPBS, 
and pelleted again.  The pellet was then mixed with 250 µl 2xSDS loading buffer 
containing 2-mercaptoethanol.  After boiling for 10 minutes, the samples were loaded and 
run on a 12% Tris-glycine precast gel (Cambrex).  Sample volumes were adjusted to 
represent equivalent cell numbers as determined by optical density measurements of each 
culture at the time of collection.  Proteins were then transferred to a polyvinylidine 
fluoride membrane using a semi-dry transfer graphite electroblotting system (Millipore).  
The membranes were then blocked for 1 hour at room temperature or overnight at 4oC in 
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5% nonfat dry milk/TBST buffer (15 mM Tris-HCl, 4 mM Tris, 137 mM NaCl, 0.1% 
Tween-20, pH 7.6).  Antibodies were diluted in 1% nonfat dry milk/TBST for 1 hour at 
room temperature.  The primary antibody used for Western blots was a monoclonal 
mouse anti-GFP (Clonetech).   
For flow cytometric analysis, cells containing the appropriate constructs were 
grown overnight in LB media with the appropriate antibiotics.  250 µl of overnight 
culture was used to inoculate 10 ml of fresh media, and growth and induction conditions 
were the same as those described above.  Cells were harvested from 1 ml of culture by 
centrifugation at 2,000 g and resuspended in 1 ml of 1xPBS.  Depending upon cell 
density, 3 to 10 µl of each sample was added to 1 ml of 1xPBS in a sieve tube before 
being analyzed on a Becton-Dickinson FACSort flow cytometer with the above settings.  
The fluorescence of individual clones was also analyzed on a fluorescence plate reader.  
Colonies were picked to individual wells of a 96-well plate (Costar brand round bottom, 
polystyrene, non-binding surface) containing 100 µl of LB media with the appropriate 
antibiotics.  After overnight growth at 37oC, new plates were subcultured by replica 
plating, grown for 1.5 hours at 37oC, and induced by the addition of arabinose and/or 
IPTG to a final concentration of 0.2% and 0.1 mM, respectively.  Following the induction 
period, the plates were centrifuged at 2,000 g for ten minutes at room temperature.  Cells 
in each well were resuspended in 100 µl of 1xPBS before being analyzed by a BioTek 
Synergy™ HT Microplate Reader using an excitation filter of 480 nm and an emission 
filter of 530 nm.  To compare fluorescence readings measured on microtiter plates with 
the fluorescence distribution of cells measured by flow cytometry, 5 µl of sample from a 




4.3.1 Fluorescent reporter system to monitor degradation by ClpXP 
GFP has been used extensively as a fluorescent reporter in E. coli [27-29], is 
easily overexpressed and folds correctly in the cytoplasm [30, 31].  By adding the C-
terminal SsrA peptide tag (AANDENYALAA) to GFP, the GFP-SsrA fusion is targeted 
to degradation by the cytoplasmic protease ClpXP [32, 33] (see Figure 4.1, adapted from 
[34]).  Due to the degradation of GFP-SsrA by ClpXP, the fluorescence of cells 
expressing GFP is much greater than cells expressing the GFP-SsrA fusion providing a 
high signal-to-noise ratio as shown in Figure 4.1B. 
 
 
Figure 4.1. Fluorescent reporter system.  (A) GFP expressed with an SsrA tag is targeted and 
degraded by ClpXP.  (B) Sample histograms showing fluorescence of GFP and GFP-SsrA 




The GFP-SsrA fusion was expressed under the control of the pBAD promoter in 
pBAD33 plasmid [24].  Expression of the fusion protein occurs upon induction of the 
cells with the addition of 20% arabinose.  However, high-level expression of the fusion 
may saturate the ClpXP machinery which is only synthesized at constitutive levels.  
Thus, the time-course of GFP-SsrA in E. coli XL1-Blue cells transformed with pGFP-
SsrA was determined by inducing cultures in mid-log phase with arabinose and analyzing 
the cell fluorescence in samples taken hourly by flow cytometry.  As shown in Figure 4.2, 
approximately five hours after induction, most of the GFP-SsrA fusion protein had been 
degraded, and the fluorescence had returned to background levels.  Therefore, five hours 
after the onset of GFP-SsrA synthesis, sorting by FACS for higher fluorescent cells than 
background could be expected to yield clones of interest. 
 
 
Figure 4.2. Time dependent fluorescence of GFP-SsrA.  The synthesis of GFP-SsrA was induced 
at t=0 and samples were taken hourly and analyzed by flow cytometry.  Sample histograms 
showing the fluorescence of the cell populations are shown at hours 1, 3 and 5.  A smoothed line 
curve connects the data points. 
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4.3.2 Genomic library screening for regulators of ClpXP 
We sought to determine if any genes present in the E. coli genome act as 
repressors of the Clp operon or inhibitors of the Clp machinery itself.  A genomic library 
was constructed and co-expressed with GFP-SsrA.  In a genomic library, the entire 
genome of an organism is broken into smaller DNA fragments which are ligated into a 
vector, typically a plasmid.  Gene fragments resulting in higher GFP-SsrA fluorescence 
may encode for factors that regulate or inhibit the Clp machinery. 
A genomic library was created by digesting E. coli genomic DNA followed by 
ligation into pTrc99A.  Digestion times were adjusted to yield DNA fragments of 
approximately 1,000 base pairs to ensure each fragment contains a single, intact gene or 
the majority of one gene.  The ligation mixture was transformed into E. coli XL1-Blue 
cells already containing pGFP-SsrA, and resulted in a library of 106 transformants.  Since 
the E. coli genome has 4,405 genes [35], each gene should be statistically represented at 
this library size.   
The synthesis of GFP-SsrA and any polypeptides encoded by the library gene 
fragment were induced and, at five hours later, the library was sorted by FACS.  1.4x107 
cells were sorted, and the top 1% of fluorescent events consisting of 1,275 were 
collected.  The collected cells were grown overnight, and 500 colonies were then 
transferred to a 96-well plate.  After subculturing to another 96-well plate for growth for 
one hour and induction for five hours, cell fluorescence was determined on a fluorescence 
plate reader.  Ten clones with fluorescence higher than the WT GFP-SsrA alone were 
selected, grown overnight, and purified plasmid was obtained from each culture.  These 
purified plasmids were used to back-transform new E. coli XL1-Blue cultures.  Back-
transformation ensures that the observed phenotypes are due to the expression of the 
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cloned gene and not from other effects which may have arisen during the growth of the 
culture. 
Induction of protein synthesis and analysis by flow cytometry revealed that the 
isolated clones were highly fluorescent as compared to the fluorescence of cells 
transformed with pGFP-SsrA together with empty Trc99A plasmid and grown under 
identical conditions (see Figure 4.3).  The genomic insert DNA in the pTrc99A plasmid 
was sequenced, and the sequences were used in a BLAST search [36].  Matches to the 
following genes were found: eno, an enolase used in energy metabolism; pyrG, a CTP 
synthetase; pspA, an inner membrane phage shock protein; pspB, an activator of pspA; 
pckA, a phosphoenolpyruvate carboxykinase; and sgcX, a putative lyase/synthase (all 
gene definitions from [37]]).  The remaining four sequences were for ribosomal proteins 
as overexpression of ribosomal proteins could increase translation [38] and overwhelm 
the ClpXP machinery.  Therefore, more GFP-SsrA would be present at the end of the five 
hour induction period, leading to higher fluorescence. 
However, only 40-60% of the full length sequence of each of the above genes was 
present in the plasmids isolated from the genomic library.  Therefore, primers were 
designed to amplify the full length of the respective genes and test their effects.  The PCR 
products were inserted into empty pTrc99A plasmid and transformed into the XL1-Blue 
strain with the GFP-SsrA construct.  Unfortunately, upon induction and analysis by flow 
cytometry, none of the full length genes resulted in higher fluorescence relative to the 
GFP-SsrA control, indicating that repression or inhibition of the Clp system did not 
occur.  Additional isolated clones were checked by plate fluorescence and flow 
cytometry, and the genomic library was sorted a second time to isolate additional 
mutants.  However, no additional clones showed an increase in fluorescence after the 
induction period. 
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The result indicates there are no gene fragments that upon multicopy expression 
serve as negative effectors of the Clp system.  The increased fluorescence of clones 
obtained from library screening was apparently due to the overexpression of chimeric or 
incomplete proteins.  Incomplete proteins are encoded in a genomic library since many 
clones contain pieces of genes which are not necessarily in the correct open-reading-
frame.  These polypeptides do not fold correctly and are thus likely to be targeted for 
degradation by the Clp system [39].  Since such proteins are overexpressed and would 
therefore be abundant, they compete with the GFP-SsrA fusion for degradation, 
increasing the fluorescence of the cell.  Additionally, out-of-frame gene fragments may 
cause ribosome stalling during translation and recruitment of the SsrA RNA which tags 
the protein with the SsrA tag for degradation [32].  This process would also lead to 
polypeptides that would compete with the GFP-SsrA fusion for ClpXP.  Such 
competition should lead to an increase in the fluorescence of the cell.  In either case, the 




Figure 4.3. Example of a fluorescence histogram for a clone isolated from the genomic library.  
Clones isolated after back-transformation were highly fluorescent as compared to cells co-
transformed with plasmid pGFP-SsrA and empty pTrc99A plasmid as a control. m, geometric 




4.3.3 Selection for intragenic mutations in GFP-SsrA leading to higher cell 
fluorescence 
4.3.3.A. GFP-SsrA library 
Mutant versions of GFP that are more resistant to ClpXP degradation may be 
more resistant to mechanical unfolding since ClpX acts by pulling the protein from one 
end and imposing a mechanical force for unfolding the protein and feeding it into the 
proteolytic chamber.  As the reporter protein, unfolded GFP is not fluorescent [31], thus 
any mutants with increased fluorescence over wild-type (WT) GFP would indicate clones 
that may be more resistant to mechanical unfolding.   
The gfp gene was subjected to random mutagenesis using error-prone PCR [25].  
The mutated gfp was then ligated into pGFP-SsrA replacing the WT gfp sequence.  The 
ligation mixture was then electroporated into XL1-Blue to create a library with 2x106 
transformants.  Five clones from the library were sequenced and averaged six mutations 
per gfp gene, giving an error rate of 0.7%. 
After growth and induction of protein synthesis, the library was then screened by 
FACS to select highly fluorescent clones.  1.3x107 events were sorted, and the top 0.03% 
fluorescent events, representing 3,455 cells, were collected.  After growth overnight, 
1,000 colonies were transferred to 96-well plates to be grown, replica plated, induced, 
and scanned by the fluorescence plate reader.  The top ten fluorescent clones were grown 
overnight for plasmid purification and back-transformed into XL1-Blue.  Flow cytometry 
showed that these clones were highly fluorescent five hours after induction (see Figure 
4.4).  However, upon sequencing the mutated gfp genes, it was discovered that all of the 
sequenced clones had a stop codon or nucleotide deletions before the SsrA tag.  Thus 
higher fluorescence occurred due to the accumulation of cytoplasmic GFP since the SsrA 
tag was missing, and the protein was not targeted to degradation by ClpXP.   
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The fluorescence level of these clones is equivalent to that of cells expressing 
GFP without an SsrA tag.  We hypothesized that any mutated GFP-SsrA would have a 
fluorescence much lower than that of cells expressing GFP alone.  Therefore, an 
additional five clones with low fluorescence as analyzed by flow cytometry were selected 
and sequenced.  Again, all of these five clones had stop codon changes before the SsrA 
tag. 
The last two codons of gfp before the SsrA tag are 5’-TACAAA-3’, and stop 
codons are encoded by the following codons: TAA, TAG and TGA.  C→A or C→G 
substitutions in position 3 and an A→T in position 4 can yield a stop codon.  Therefore, a 
new reverse primer that encodes these two codons was made so that no mutations could 
occur in them during error-prone PCR.  A new library was constructed with this primer to 
yield 5.1x106 transformants with an error rate of 0.3% or 2.1 nucleotide substitutions per 
gene based on the sequencing of nine clones.  From this library, 4,311 cells were 
collected from a total of 2.2x107 analyzed events representing the top 0.02% of the 
fluorescent events.  1,000 clones were grown and analyzed individually on the 
fluorescence plate reader, and the top ten were further analyzed by flow cytometry.  
Sequencing results indicated that two of these clones had stop codons upstream of the 
new primer and SsrA tag, and the other eight clones had 1 or 2 base pair deletions in the 
last 30 nucleotides of gfp, rendering the SsrA tag out-of-frame.  Again, since the clones 
with the highest fluorescence had been examined and their fluorescence was similar to 
that of untagged GFP, the library was resorted, and clones with low fluorescence as 
compared to cells expressing intact GFP without an SsrA tag were selected.  Analysis of 
1.7x107 events yielded 2,714 cells or 0.03% of the analyzed events.  500 clones were 
grown and analyzed individually on the fluorescence plate reader.  The 26 most 
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fluorescent clones were analyzed by flow cytometry and sequenced.  However, results 
again showed 10 stop codon errors and 16 base pair deletions in 26 sequenced clones. 
 
 
Figure 4.4. Example of a fluorescence histogram of a clone isolated from the mutated gfp library.  
Clones isolated after back-transformation were highly fluorescent as compared to WT GFP-SsrA.  
m, geometric mean of the fluorescence. 
 
4.3.3.B. Placing the SsrA degradation tag at the N-terminus of GFP 
In order to resolve this problem, I constructed a SsrA-GFP construct since 
previous work has shown that the Clp system can recognize and degrade proteins with N-
terminal, C-terminal, or internal tags [40].  Since the SsrA tag is now upstream of GFP, 
any mutations in gfp that caused stop codons or nucleotide deletions to occur would not 
affect the SsrA tag.  E. coli XL1-Blue cells were transformed with the ssra-gfp gene after 
cloning and verification by sequencing.  Triplicate cultures were grown and induced at 
0.1% and 0.2% arabinose induction levels, and samples were analyzed hourly by flow 
cytometry.  As seen in Figure 4.5, the fluorescence did not decrease to baseline levels as 




Figure 4.5. Time dependence of cell fluorescence in cells expressing SsrA-GFP.  Flow 
cytometric analysis of SsrA-GFP in E. coli XL1-Blue for two different induction levels of 
arabinose, 0.2% and 0.1%.  Error bars represent the standard deviation of the three samples per 
time point, and the line represents the average. 
 
An attempt was made to alter the growth conditions of cells containing the SsrA-
GFP fusion to reduce the high background fluorescence.  The expression of SsrA-GFP in 
plasmid pSsrA-GFP is under control of the pBAD promoter.  Protein synthesis is induced 
by arabinose, but it can also be repressed with glucose [24].  Cells with the pSsrA-GFP 
construct were grown using the conditions described above and induced to a 0.1% final 
arabinose concentration.  However, after one hour of induction, the cultures were 
individually subjected to the following conditions: (A) cells from one culture were 
pelleted and resuspended and grown in fresh LB media with a concentration of 0.2% 
glucose, (B) a second culture had glucose added to achieve a final concentration of 0.2% 
glucose and (C) cells from a final aliquot were pelleted and resuspended and grown in 
fresh LB media.  Figure 4.6 shows the results obtained for the three cultures.  As 
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compared to the 0.1% arabinose culture in Figure 4.5, these cultures had lower maximum 
cell fluorescence and a lower level of baseline fluorescence except for the case of the 
culture with just the added glucose.  The culture that was resuspended and regrown in 
fresh LB media had the mean fluorescence level of approximately 50.   
Isolating positive clones over this background mean fluorescence would be 
difficult.  As can be seen in Figure 4.7, there is considerable overlap between the culture 
fluorescence after 1 hour, when expression is at a maximum and after six hours.  Because 
of the variance in each culture, it is not possible to distinguish between clones that have 
higher fluorescence due to physiological reasons and those that might express a mutated, 
more stable SsrA-GFP.  In other words, the signal to noise is such that an unacceptably 
high number of false positive clones would be expected to arise during screening.  Hence, 
a library was not constructed as isolating clones of interest from the false positives would 





Figure 4.6. Time dependence of cell fluorescence in cells expressing SsrA-GFP with repression.  
Flow cytometric analysis of SsrA-GFP in E. coli XL1-Blue grown at 37oC for one hour before 
induction by 0.1% arabinose at t=0.   At one hour following induction, the following conditions 
were implemented: (A) cells were pelleted and recultured in fresh LB media with a concentration 
of 0.2% glucose, (B) glucose was added to the culture to a concentration of 0.2% and (C) cells 
were pelleted and recultured into fresh LB media.  Error bars represent the standard deviation of 
the three samples per time point, and the smoothed line curve represents the average. 
 
 
Figure 4.7. Overlay of histograms for cell culture in condition C.  Histograms from flow 
cytometric analysis of cells that were pelleted and recultured into fresh LB media at one hour 
after induction (mean approximately 325) and six hours after induction (mean approximately 50). 
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4.3.3.C. GFPxho-SsrA library 
As discussed above, selection for the GFP-SsrA mutant conferring higher 
fluorescence yielded only stop codons and base pair deletions.  To overcome these 
problems, a restriction site was engineered into the gfp gene.  All of the residues in GFP 
are necessary for fluorescence except the last eight as determined from truncation studies 
[30, 31].  Therefore, only the N-terminus of the protein was subjected to mutagenesis.  A 
restriction site was placed at a codon 52 amino acids from the C-terminus of GFP.  Any 
mutation that introduces a stop codon within the first 186 residues of GFP should render 
the GFP non-fluorescent and reject it from being collected during sorting.  Base pair 
deletions could allow the translation of almost full length protein, however, the codons 
after the deletion would be out-of-frame and as a result, the remainder of the polypeptide 
would encode an unrelated amino acid chain.  Deletions in codons near the end of the 
polypeptide chain may still allow GFP to be fluorescent.  Since the restriction site was 
placed at a codon distant from the C-terminus, this ensures that enough mutations 
following a base pair deletion would render GFP non-fluorescent.  Flow cytometric 
analysis of the GFPxho-SsrA fusion under the same growth and induction conditions as 
the GFP-SsrA fusion indicated that the introduced restriction site did not interfere with 
fluorescence of GFP as the time dependent fluorescence was equivalent to that shown in 
Figure 4.2. 
Error-prone PCR was conducted on the first 558 nucleotides of gfp, and these 
fragments replaced the WT sequence of gfp upon ligation into pGFPxho-SsrA.  
Transformation into E. coli XL1-Blue resulted in a library with 2x107 transformants.  
Sequencing of ten clones indicated, on average, the presence of eight mutations per the 
first 558 nucleotides of gfp for an error rate of 1.4%.  Following FACS screening of the 
library, 6,329 events representing the top 0.02% of fluorescence were isolated from a 
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total of 2.8x107 events.  It should be noted that the fluorescence of the library was 
equivalent to that of WT GFPxho-SsrA, and no highly fluorescent events were observed.  
In order to collect the highest fluorescent events available, the lower end of the sort gate 
was set at a fluorescence of 20.  Since the geometric mean of the library population was 
approximately 8, this small separation between the mean and the sort gate would result in 
the collection of WT clones, i.e. GFPxho-SsrA with no mutations.  Indeed, 500 colonies 
were scanned by fluorescence plate reader and all clones were equal or less fluorescent 
than the GFPxho-SsrA parental protein. 
Since analysis of this library during sorting indicated that no events had higher 
fluorescence than cells expressing GFPxho-SsrA, it was possible that the high error rate 
used in the construction of the library introduced too many substitutions into the gfp 
gene, limiting the fraction of proteins that retained activity.  Only the clones with few 
mutations would likely be fluorescent and because these clones would be statistically 
under-represented in a high error rate library, the probability of finding a clone with 
increased stability of GFP would be small.  Hence, a new library with an error rate of 
0.3% or 1.7 mutations per gfp gene was constructed.  This library of 5x106 transformants 
was sorted, and the top 0.001% fluorescent events, representing 263 out of 2.6x107 total 
events, were collected.  During sorting of this library, events with slightly higher 
fluorescence were detected so the lower end of the sort gate was set at a fluorescence of 
40.  However, all the collected events were equal or less fluorescent than the parental 
GFPxho-SsrA fusion when analyzed by the fluorescence plate reader.  In addition, several 
clones were randomly checked by flow cytometry, and all showed fluorescence 
equivalent to that of GFPxho-SsrA (see Figure 4.8).  In order to ensure that the expression 
of the mutant construct was equivalent to the WT construct, five clones were grown and 
protein synthesis was induced with arabinose.  Cells from each clone culture along with a 
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WT culture were harvested after one hour of induction and the level of GFP protein was 
determined by Western blotting (see Figure 4.9).  The Western blot indicated that 
expression of mutant GFPxho-SsrA fusion in the clones was the same as for the cells 
expressing the parental protein.  Therefore, no mutations that increased the stability of 
GFP against degradation by ClpXP, as indicated by the low fluorescence of the library, 




Figure 4.8. Fluorescence histograms from flow cytometric analysis of cells expressing a mutant 
GFPxho-SsrA collected from sorting and the WT control GFPxho-SsrA fusion. m, geometric 





Figure 4.9. Western blot of GFPxho-SsrA and mutant proteins.  Cells were grown for one hour at 
37oC in LB media before protein synthesis was induced with 0.2% arabinose.  Cells were 
collected after one hour of induction from the WT control and five sample mutants.  Lanes were 




4.3.3.D. GFP-RepA  
The above studies indicate that random mutants of GFP-SsrA with increased 
stability against degradation by ClpXP could not be isolated.  We therefore decided to 
investigate the possibility of using the same experimental process to isolate mutants with 
increased stability against ClpAP.  ClpAP unfolds proteins in a manner similar to that of 
ClpXP.  The RepA peptide tag targets proteins for degradation by ClpAP [41].  RepA is a 
molecular chaperone that initiates DNA replication from a plasmid that contains a P1 
origin [42].  The first 15 amino acids of RepA contains the ClpA recognition signal 
which is sufficient to target a tagged protein to degradation by ClpAP [41]. 
A GFP-RepA fusion was constructed and expressed from plasmid pGFP-RepA.  
Cells were grown and induced under the same conditions used for the expression of GFP-
SsrA, and samples were analyzed hourly by flow cytometry.  As shown in Figure 4.10, 
the fluorescence of the GFP-RepA fusion barely increases over background, reaching a 
fluorescence height of 10 versus 200 for GFP-SsrA.  Different levels of inducer were 
tested, but the maximum fluorescence never increased to a level that would allow clones 
to be isolated from a sort.  This low maximum fluorescence could be due to low 
expression levels of the construct or perhaps higher degradation efficiency of GFP-RepA 
by ClpAP compared to the degradation of GFP-SsrA by ClpXP.  No further experiments 
were conducted to examine expression levels since increasing expression levels high 
enough to achieve greater fluorescence would be difficult and could be toxic to the cell, 
in turn, creating growth and induction problems.  Therefore, no library was fabricated 





Figure 4.10. Time dependent cell fluorescence of GFP-RepA.  Cultures were grown in triplicate 
for each induction level with conditions described previously.  Samples were taken every hour 
and analyzed by flow cytometry.  Error bars represent the standard deviation of the three samples 











By using the GFP-SsrA fluorescent reporter protein fusion, we sought to discover 
multicopy genes or intragenic mutations that inhibit degradation by the ClpP proteolytic 
machinery of E. coli.  Turning off or inhibiting the Clp system via the expression of a 
genomic DNA fragment would allow greater yields of protein to be produced since 
cytoplasmic proteolysis would be reduced.  However, the Clp system must also retain its 
function to carry out its cellular roles during growth phases.  Thus, inducible regulation 
of the activity of the Clp machinery could be important for recombinant protein 
production. 
Unfortunately, screening of the genomic library by FACS did not yield any genes 
that showed reduced degradation of GFP-SsrA in the cell.  Although the screen yielded 
several clones that conferred higher fluorescence, further examination revealed that they 
encoded only portions of genes that presumably gave rise to incomplete polypeptides that 
serves as competitive substrates for ClpXP degradation.  The role of SsrA tagging is to 
direct incomplete polypeptides for degradation.  Therefore, the finding that 
overexpression of incomplete polypeptides, such as those isolated from the genetic 
screen, inhibited degradation of GFP-SsrA by presumably serving as competitive 
inhibitors is not unexpected and is of little significance.   
It should be noted that with the exception of SspB, other genetic studies have also 
failed to reveal regulators or inhibitors of the Clp system.  The SspB protein acts as an 
adaptor protein for the ClpX chaperone [43].  The SspB protein recognizes the SsrA tag 
and tethers tagged proteins to ClpX, enhancing the rate of degradation [44].  Increasing 
the amount of SspB will increase the degradation rate of SsrA tagged proteins, but since 
ClpXP can degrade these tagged proteins even without SspB, it is not useful as a method 
of regulation [45]. 
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We also searched for intragenic mutations in GFP that could decrease its 
degradation by ClpXP or ClpAP.  Based on the mechanism of action of the ClpA and 
ClpX chaperones, mutations conferring resistance to degradation would be likely to 
exhibit greater stability to unfolding from with the N- or C-terminal end.  By using the 
SsrA tag to target GFP to the ClpXP machinery, mutations could be introduced into gfp 
that would make it more resistant to degradation allowing differences in fluorescence to 
be used to isolate these mutants.  
Initial experiments to isolate clones expressing GFP-SsrA and exhibiting higher 
fluorescence yielded false positive mutants in which the SsrA tag was missing or out-of-
frame due to the introduction of stop codons or base pair deletions.  The Taq polymerase 
used in the error-prone PCR to mutate the GFP gene has a normal error rate of 
approximately 1 error per 10,000 bases [46].  However, the basis of the error-prone PCR 
procedure is to increase the mutation rate, and these error rates are reported above for 
each library.  Since the selection pressure of high fluorescence was applied and a large 
number of events were analyzed, these false positives would dominate the collected 
events, making the isolation of real positives difficult. 
Changing the placement of the SsrA tag to the N-terminus or utilizing a different 
tag did not provide a useful strategy for screening due to the low fluorescence and the 
low signal-to-noise ratio that resulted.  In the case of SsrA-GFP, the baseline 
fluorescence did not decrease to a low enough level to allow the discrimination of true 
positives from cells expressing unmutated SsrA-GFP.  For GFP-RepA, the maximum 
fluorescence barely increased over baseline levels.  In either case, the sort region would 
have to overlap the fluorescence distribution exhibited by cells expressing the respective 
unmutated protein thus leading to an unacceptably high frequency of false positives. 
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In a separate effort, a restriction site was engineered into gfp at a position 
corresponding to the codon 52 amino acids from its C-terminus.  The introduction of this 
restriction site allowed the mutagenesis of only the first 558 of 714 nucleotides of gfp in 
the GFP-SsrA fusion.  This strategy eliminated false positives due to stop codons or 
deletions since such mutants would not produce fluorescent GFP.  Screening of two 
libraries with different error rates, however, did not yield any clones with increased 
fluorescence over WT GFP.  This indicated that no mutations could stabilize GFP against 
degradation by ClpXP while still maintaining its fluorescence. 
Since the completion of these studies, new insights have been discovered about 
the mechanism of protein stability to degradation by the Clp machinery.  By using 
different mutants of the same protein, the rate of degradation by ClpXP of these proteins 
was shown not to depend on the global stability of the protein, as determined by the free 
energy of unfolding [47].  Rather, the local structure of the protein adjacent to the tag 
influenced the rate of degradation and ATP consumption during the degradation process 
[15].  Furthermore, it was determined that proteins with an alpha helix or irregular loops 
next to the degradation tag were unfolded more easily than proteins that had beta strands 
next to the tag [15, 48]. 
In light of these findings, our approach to change the overall stability of GFP 
would then have had no effect on increasing its resistance to degradation against ClpXP.  
In addition, since GFP is an all beta-sheet protein, its resistance to degradation may 
already be at a maximum.  Bohn et al. found that GFP-SsrA could not be stabilized 
against ClpXP as well with the use of mutational insertions [49].  Also, resistance to 
degradation could not be achieved by screening a genomic library to find chaperones that 
would stabilize GFP-SsrA against ClpXP [49].  Finally, using transposon mutagenesis, 
 126
Bohn et al. found that only inactivation of clpX or clpP resulted in stabilization of GFP-
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Conclusions and Recommendations 
 
In this work, we applied the high throughput method of fluorescence activated 
cell sorting (FACS) to investigate protein export and engineering.  Using directed 
evolution to mutate the genes of interest and then linking a cell’s genotype to a 
fluorescent phenotype, FACS allowed us to screen millions of mutants quickly and 
efficiently. 
We have used FACS to investigate problems related to protein export via the Tat 
pathway and protein stability to mechanical unfolding and resistance to proteolysis by the 
Clp system of E. coli. 
We examined ways to increase recombinant protein yields in the E. coli periplasm 
through the Tat pathway.  The Tat pathway also offers a quality control advantage in that 
it exports only correctly folded proteins.  This is especially useful for antibody fragment 
production since the Tat pathway will ensure that only correctly folded fragments in 
which disulfide bond formation has occurred are transported to the periplasm in an 
oxidizing cytoplasm strain.  Therefore, only the periplasmic fraction of the cells needs to 
be harvested and only fully functional antibody fragments would be obtained. 
Since the efficiency of the Tat pathway is low, we used FACS to screen mutants 
of the anti-digoxin 26-10 scFv that exhibit improved Tat export.  We isolated a mutant 
scFv C8 that is produced at an increased periplasmic yield of approximately two-fold 
over the WT scFv.  Further analysis of the clone revealed that the mutations increased the 
rate of refolding 2.5 times that of the WT 26-10.  This faster refolding rate likely keeps 
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the mutant protein from participating in off-pathway reactions such as protein 
aggregation, thereby allowing more competent protein to be available for Tat export.   
However, since this improved yield is still lower than that achieved when export 
is targeted to the Sec pathway, additional experiments were conducted to further increase 
the yield.  Using various E. coli mutants having different mutations that render the 
cytoplasm oxidizing, as required for disulfide bond formation, or changing the growth 
conditions did not increase the fluorescence.  By co-expressing different proteins that 
could alleviate the saturation of the Tat pathway or provide chaperone functions, we 
determined that co-expression of the Tat translocon genes yield the largest improvement 
in cell fluorescence and therefore export yield.  Overall, co-expression of the TatABC 
proteins with the C8 mutant scFv resulted in an increase in fluorescence that was five 
times greater than the fluorescence obtained by exporting the parental anti-digoxin scFv.  
Even so, this maximum fluorescence was only 16-fold over background which is still 
approximately half that achieved through the Sec pathway.  Thus, additional methods of 
improvement may need to be investigated in order to increase the level of Tat export such 
as engineering a better strain based on the FA113 strain.   
In other studies, we sought to discover any regulators or inhibitors of the Clp 
system present in E. coli utilizing the GFP-SsrA fluorescent reporter protein fusion.  
Finding novel regulators of the Clp system, apart from its biological significance could 
help suppress proteolysis and thus allow increased yields of protein to be produced in E. 
coli.  However, screening of the genomic library did not yield any genes that played a 
role in the regulation or inhibition of the Clp system.  This is most likely due to the fact 
that the Clp system is used to regulate many cellular processes, and its down-regulation 
may be detrimental.   
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The same fluorescent construct was used to explore the engineering of more 
resistant proteins to mechanical forces and possibly to shear.  Since the Clp system 
unfolds proteins by applying a mechanical force, determining ways to increase a protein’s 
stability against Clp degradation may correlate with a higher resistance to shear.  
However, after several different libraries were constructed and screened, no mutations 
were found that could stabilize GFP against the Clp system.  Research conducted after 
this study found that resistance to degradation by the Clp system depends on local 
stability near the degradation tag rather than the global stability of the protein.  Hence, 
although mutations in gfp could perhaps increase the global stability of the protein, they 
would be unlikely to increase the protein’s resistance to shear, given that GFP folds into a 





5.1 Recommendations for future studies 
5.1.1 Reducing ClpXP degradation                              
Although the screening of a genomic library did not yield any genes which inhibit 
the ClpXP machinery, other approaches could be tried to reduce proteolysis.  As 
discussed in Chapter 1, the SspB protein has a C-terminal XB peptide motif that is 
involved in flexible tethering to ClpX.  The SspB adaptor recognizes the tag then 
dimerizes with another SspB adaptor to deliver the tagged substrate to ClpX using the 
two XB peptide motifs to anchor the dimerized adaptor to ClpX. 
By altering the residues of SspB that recognize the SsrA tag, a mutant SspB 
protein could be engineered which only binds but does not translocate the tag.  This 
would allow the SspB adaptor to recognize a substrate, dimerize and associate with 
ClpXP.  By not being able to translocate the tag, the SspB dimmer would effectively be 
blocking that ClpXP molecule from carrying out degradation.  However, since the 
association and disassociation of the SspB dimer to ClpXP is an equilibrium process and 
ClpXP can degrade tagged substrates in the absence of SspB, it will also be necessary to 
evolve the XB peptide motifs and flexible linker that tethers the SspB dimer to ClpXP.  
By increasing the affinity of the SspB dimmer to ClpXP, overexpression of this mutant 
SspB could effectively block all the constitutively expressed ClpXP molecules.  As this 
may affect cell viability and growth, having the mutant SspB on an inducible plasmid 
may allow it to be overexpressed only when the recombinant protein of interested is 
expressed.  
This proposed study could be conducted in the same manner as the completed 
study in Chapter 4.  Use of the GFP-SsrA construct co-expressed with mutant SspB 
libraries would allow the use of FACS as a high throughput screening method.  This 
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project can be done in two stages by creation of a library of SspB mutants in which 
amino acid substitutions in the SsrA recognition site have been made followed by another 
library in which amino acid substitutions have been made in the flexible tether of the 
most fluorescent mutant SspB proteins isolated from the first library.  On the other hand, 
one library could be constructed where mutations are made in both the SsrA tag 
recognition site and the flexible tether.  Either way, mutants of SspB that only bind the 
SsrA tag and associate with ClpXP with a higher affinity would have higher fluorescence 
since less GFP-SsrA would be degraded over time than WT versions of SspB.  This 
would allow rapid and efficient screening of the mutants by FACS and would yield a 
means to selectively inhibit the ClpXP system. 
 
5.1.2 Further increasing Tat export efficiency 
As seen in Chapter 3, co-expression of TatABC with the C8 ssTorA-26-10 scFv 
resulted in a five-fold increase over WT ssTorA-26-10 scFv expressed alone.  However, 
in order to match the export efficiency of the Sec pathway, further improvements must be 
made.  Only then can the Tat pathway become a viable means of recombinant protein 
production for biotechnology. 
Since co-expression of all the various proteins examined in Chapter 3 produced an 
increase in fluorescence, it may be possible to place some of these proteins under 
inducible control on the E. coli chromosome.  This would allow additional proteins to be 
co-expressed with the C8 ssTorA-26-10 scFv without having to contend with plasmid 
incompatibility or plasmid loss.  For example, a FA113 strain in which the TorD and 
TatABC genes were placed under inducible control was created.  However, upon 
induction of these genes and the WT ssTorA-26-10 scFv no fluorescence improvement 
was observed.  This was most likely due to the incorrect placement of the genes on the 
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chromosome or the introduction of errors into these genes during the genetic 
recombination process used to create the new strain.  Therefore, more testing and 
troubleshooting of the strain will be necessary. 
When a new strain of FA113 is successfully created, the inducible combination of 
TorD and TatABC on the chromosome would allow the co-expression of another protein 
from a plasmid like PspA.  Although individually TorD, TatABC and PspA increased the 
fluorescence of the C8 scFv 2.4, 1.3- and 1.5-fold, respectively, their combination most 
likely will not result in a total cumulative gain since the Tat pathway may reach a 
maximum export rate.  However, their combination may improve the C8 scFv 
fluorescence 3- to 3.5-fold over the C8 scFv fluorescence alone.  With the two-fold 
improvement of the C8 scFv over WT, this total improvement could increase protein 
expression seven times over WT leading to a purified yield of 0.91 mg/L/OD based on 
the yield values from Chapter 3.  This value is significantly closer to the 1 g/L/OD values 
obtained for proteins exported via Sec. 
Finally, the new strain with the C8 ssTorA-26-10 construct will need to be 
cultured in a stirred tank bioreactor to determine the actual yields that can obtained.  This 
approach would allow for better mixing and oxygen transfer rates than the shake flasks 
used in the mid-scale expression experiments in Chapter 2.  The growth conditions can 
also be optimized again since growth in these experiments in Chapter 3 may have been 
oxygen limited.  Also, the implementation of pH control on the bioreactor would improve 
cell viability by maintaining a pH that is optimal for E. coli strain growth.  These 
improvements may increase cell densities allowing an even greater yield of 26-10 scFv 
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